Achilles tendinitis

M13_ACHILLESTEND

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M76.6 Hospital discharge: ICD-9 — 7267A Cause of death: ICD-10 — M76.6 Cause of death: ICD-9 — 7267A 2 out of 7 registries used, show all original rules.	5234
4. Check minimum number of events None	5234
5. Include endpoints None	5234
6. Filter based on genotype QC (FinnGen only)	4772

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M76
Name in latin: Tendinitis tendinis Achillis

NAME	M13_ACHILLESTEND
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M766
HD_ICD_9	7267A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M766
COD_ICD_9	7267A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Achilles tendinitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	26379	12438	13852
Only index persons	25665	12199	13466
Unadjusted period prevalence (%)
Whole population	0.37	0.36	0.39
Only index persons	0.48	0.45	0.51
Median age at first event (years)
Whole population	50.12	51.73	48.70
Only index persons	50.02	51.68	48.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4772	2603	2169
Unadjusted period prevalence (%)	0.96	0.92	0.99
Median age at first event (years)	53.73	52.92	54.70

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4905: Matched controls
49050

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

682.1

307.7

1109

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

16.0

307.7

436

298

M48.0

ICD-10 Finland

Spinal stenosis

31.3

307.7

591

214

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

19.1

307.7

511

297

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

25.6

307.7

831

388

M54.5

ICD-10 Finland

Low back pain

3.4

307.7

1944

7996

M76.6

ICD-10 Finland

Achilles tendinitis

1037.9

307.7

4634

795

7267A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of ankle and tarsus[TENDINITIS SEU BURSITIS ACHILLIS]

+∞

307.7

330

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

15.9

307.7

586

416

N03AX16

ATC

[U] pregabalin

3.8

307.7

1237

3962

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

91.5

307.7

227

M54.4

ICD-10 Finland

Lumbago with sciatica

5.1

307.7

983

2282

NHL10

NOMESCO Finland

Suture or reinsertion of achilles tendon

15.1

307.7

290

203

S86.0

ICD-10 Finland

Injury of Achilles tendon

12.8

307.7

569

496

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

48.7

307.7

315

L16

ICPC

Ankle symptom/complaint

4.6

307.7

1108

2913

M01AH05

ATC

etoricoxib; oral

3.4

304.8

3708

23352

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

13.1

304.0

296

239

N02AX02

ATC

tramadol; systemic, rectal

3.0

300.0

2373

11755

9477

FHL

Cleansing or splitting of a tendon or tendon sheath (eg tenosynovectomy, tenolysis)

60.2

292.5

163

N03AX12

ATC

[U] gabapentin; oral

4.4

292.1

830

2154

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

87.2

273.5

144

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.8

272.8

2548

13590

M79.6

ICD-10 Finland

Pain in limb

2.8

270.0

2593

14007

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

6.4

267.9

470

798

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

16.8

257.4

217

135

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

18.1

255.3

207

119

M02AA07

ATC

piroxicam; topical

2.7

238.5

2091

10611

NH4AE

NOMESCO Finland

Achilles tendon ultrasound examination

23.9

235.7

169

M43.1

ICD-10 Finland

Spondylolisthesis

18.7

222.0

177

M25.5

ICD-10 Finland

Pain in joint

2.6

219.8

1988

10151

M47.9

ICD-10 Finland

Spondylosis, unspecified

31.5

216.6

141

N02AJ06

ATC

codeine and paracetamol; systemic

2.5

207.5

2389

13563

M01AC06

ATC

meloxicam; systemic, rectal

2.5

206.8

2067

10993

M47.82

ICD-10 Finland

Other spondylosis, cervical region

12.7

200.2

197

161

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.1

195.1

587

1569

M01AB05

ATC

diclofenac; systemic, rectal

2.6

193.6

3571

24798

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

11.1

188.9

203

190

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

21.3

187.9

141

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.6

186.2

1518

7267

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.9

180.9

580

1620

M03BX02

ATC

tizanidine; oral

2.4

176.9

3259

22166

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.6

176.4

1290

5837

L17

ICPC

Foot/toe symptom/complaint

2.4

170.8

1749

9229

M54.3

ICD-10 Finland

Sciatica

6.4

168.7

287

469

L03

ICPC

Low back symptom/complaint

2.5

163.8

1405

6825

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.9

159.1

252

382

M70.6

ICD-10 Finland

Trochanteric bursitis

3.1

158.1

739

2619

M01AH01

ATC

celecoxib; oral

2.7

152.1

964

4029

M45

ICD-10 Finland

Ankylosing spondylitis

43.6

151.1

M01AE02

ATC

naproxen; oral, rectal

2.2

150.5

2932

19813

N02BF01

ATC

gabapentin; oral

3.7

148.9

521

1538

NH1BG, ,

SPAT

7.4

145.9

215

301

M02AA10

ATC

ketoprofen; topical

2.7

143.1

952

4067

M03BC01

ATC

orphenadrine (citrate); systemic

2.5

143.0

1161

5455

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.1

142.1

651

2273

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

697.6

138.5

136

M01AX17

ATC

nimesulide; oral

2.4

136.4

1231

6049

NH2AA

NOMESCO Finland

Heel X-ray examination

14.7

135.0

121

N06AX21

ATC

duloxetine; oral

3.2

133.0

593

2034

M01AE03

ATC

ketoprofen; systemic, rectal

2.1

132.3

1860

10929

M54.1

ICD-10 Finland

Radiculopathy

8.6

126.3

163

195

M76.7

ICD-10 Finland

Peroneal tendinitis

13.8

124.7

116

M01AH02

ATC

rofecoxib; oral

2.9

123.6

643

2404

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

3.1

121.7

567

1991

M43.0

ICD-10 Finland

Spondylolysis

41.2

120.8

M54.2

ICD-10 Finland

Cervicalgia

3.9

120.1

378

1034

H02AB06

ATC

prednisolone; systemic

2.0

116.3

2382

15827

N02BE01

ATC

paracetamol; systemic, rectal

3.1

114.6

4469

37770

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

8.1

112.5

153

195

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

111.4

1331

7258

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

20.8

111.1

A02BC05

ATC

esomeprazole; systemic

2.0

110.8

2032

12936

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.7

110.5

697

2873

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

9.9

107.4

124

128

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.5

107.3

785

3472

S18

ICPC

Laceration/cut

1.9

106.9

2386

16165

L15

ICPC

Knee symptom/complaint

2.1

106.8

1371

7663

A02BC02

ATC

pantoprazole; systemic

2.0

106.4

3396

25909

X58

ICD-10 Finland

Exposure to other specified factors

2.4

106.1

854

3945

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

529.2

105.1

104

B01AB05

ATC

enoxaparin; parenteral

2.0

103.1

1626

9768

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

216.6

102.9

106

J01FA10

ATC

azithromycin; systemic

1.9

101.7

2885

21004

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

20.8

100.6

WX320

NOMESCO Finland

Spinalanesthesy

2.1

100.3

1329

7490

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

99.3

L13

ICPC

Hip symptom/complaint

2.2

98.9

966

4834

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.5

98.2

689

2980

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.8

97.9

542

2083

R03AC02

ATC

salbutamol; inhalant

1.9

97.6

2674

19146

M76.0

ICD-10 Finland

Gluteal tendinitis

7.1

97.4

149

217

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

96.8

1029

5323

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

9.3

96.2

116

127

N06AA09

ATC

amitriptyline; systemic

3.1

95.5

428

1463

J01DB01

ATC

cefalexin; oral

2.2

94.2

4117

34288

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

9.3

93.5

113

124

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

13.4

93.0

A02BC03

ATC

lansoprazole; oral

2.0

92.5

1318

7588

NH4AE, ,

SPAT

12.9

92.3

N02BF02

ATC

pregabalin; oral

3.5

91.8

338

1024

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

27.3

90.9

L86

ICPC

Back syndrome with radiating pain

4.2

90.6

254

637

M01AX05

ATC

glucosamine; oral

2.2

90.5

884

4409

J01AA02

ATC

doxycycline; systemic

2.0

89.6

3849

31444

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.2

89.3

382

1269

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

88.6

679

3050

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

87.6

1701

10826

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.9

87.5

436

1580

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

86.9

1229

7035

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.5

85.9

170

320

M50.3

ICD-10 Finland

Other cervical disc degeneration

11.2

85.0

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

29.8

84.5

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.0

83.2

394

1387

M01AE01

ATC

ibuprofen; systemic, rectal

2.7

82.7

4511

39621

R51.80

ICD-10 Finland

Headache

2.3

82.5

722

3430

R01AD09

ATC

mometasone; nasal

1.8

82.1

2232

15649

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

81.6

547

2306

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.8

80.6

186

400

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

80.5

1278

7581

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

78.5

618

2802

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

78.3

M79.1

ICD-10 Finland

Myalgia

2.2

78.3

727

3535

L08

ICPC

Shoulder symptom/complaint

1.9

77.6

1170

6809

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

15.0

76.8

ZXA00

NOMESCO Finland

Right side

1.9

76.4

1234

7342

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

75.8

670

3189

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

7.0

75.3

116

170

M54.6

ICD-10 Finland

Pain in thoracic spine

3.2

75.3

317

1041

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.9

75.3

376

1362

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

74.3

1093

6297

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

73.4

2406

17591

G47.3

ICD-10 Finland

Sleep apnoea

1.9

73.2

1246

7524

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.2

72.9

666

3211

H02AB04

ATC

methylprednisolone; systemic

2.2

71.8

728

3658

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

187.8

71.3

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.4

70.7

549

2468

ZXA05

NOMESCO Finland

Left side

1.9

70.4

1126

6653

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

70.1

710

3564

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

69.2

894

4910

R06.0

ICD-10 Finland

Dyspnoea

1.9

69.2

1206

7318

M01AB55

ATC

diclofenac, combinations; oral

3.1

69.1

301

1008

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.9

68.9

208

550

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.3

68.6

554

2532

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

68.4

1312

8195

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

68.3

1056

6163

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

68.3

491

2131

M71.5

ICD-10 Finland

Other bursitis, not elsewhere classified

12.9

67.4

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.5

67.3

480

2075

J01FA06

ATC

roxithromycin; oral

1.7

67.2

1852

12821

9211

FHL

Exploration or removal of diskusprolapse

336.7

66.7

J01FF01

ATC

clindamycin; systemic

1.8

66.2

1317

8305

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

65.8

556

2589

M01AC01

ATC

piroxicam; systemic, rectal

2.2

65.8

638

3144

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.5

65.6

127

234

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.8

65.5

360

1370

R52.9

ICD-10 Finland

Pain, unspecified

2.4

65.3

503

2250

M01AH03

ATC

valdecoxib; oral

2.9

64.8

317

1133

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.2

64.7

598

2889

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

64.7

1263

7911

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

63.5

901

5097

L28

ICPC

Limited function/disability (L)

2.0

63.2

779

4196

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.9

63.1

306

1089

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

4.7

63.0

149

327

S83.2

ICD-10 Finland

Tear of meniscus, current

2.5

62.9

423

1778

R03DC03

ATC

montelukast; oral

2.0

61.9

801

4388

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.9

61.8

142

A01

ICPC

Pain general/multiple sites

2.5

61.1

432

1858

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

60.8

820

4554

J01DA01

ATC

[U] cefalexin

1.6

60.3

2852

22472

J01MA02

ATC

ciprofloxacin; systemic

1.7

59.7

1773

12422

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

59.7

1387

9100

E66.8

ICD-10 Finland

Other obesity

2.8

59.4

323

1221

M54.8

ICD-10 Finland

Other dorsalgia

3.7

59.2

190

524

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.9

58.9

132

277

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

58.9

2509

19218

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.1

58.9

102

169

M79.7

ICD-10 Finland

Fibromyalgia

4.2

58.9

158

383

SPAT1153

SPAT

Removal of sutures

1.7

58.5

1398

9232

UJF32

NOMESCO Finland

Coloscopy

1.8

58.0

1170

7365

R01AD58

ATC

fluticasone, combinations; nasal

1.8

57.2

1220

7798

G44.2

ICD-10 Finland

Tension-type headache

2.1

57.0

583

2924

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.2

56.0

499

2369

M54

ICD-10 Finland

Dorsalgia

2.2

55.4

526

2562

R01AD12

ATC

fluticasone furoate; nasal

1.7

55.2

1506

10274

A02BC01

ATC

omeprazole; systemic

1.7

54.7

1149

7300

J02AC01

ATC

fluconazole; systemic

1.6

54.1

1785

12763

M01AX01

ATC

nabumetone; oral

3.4

54.0

203

621

R03BA05

ATC

fluticasone; inhalant

1.9

53.9

828

4783

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

5.7

53.8

101

181

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

8.2

53.3

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.5

53.1

351

1461

L01

ICPC

Neck symptom/complaint

2.0

53.1

701

3852

XA402

NOMESCO Finland

ENMG

5.0

53.0

114

231

R4110, ,

SPAT

2.0

52.6

640

3416

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

51.9

1033

6450

J01FA09

ATC

clarithromycin; systemic

1.7

51.7

1456

9979

R01AD08

ATC

fluticasone; nasal

1.7

51.5

1353

9109

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.4

51.3

386

1703

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.9

51.2

245

864

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

50.8

394

1762

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

50.5

3432

28893

R52.2

ICD-10 Finland

Other chronic pain

3.7

50.1

160

440

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

49.7

1140

7393

Z50.1

ICD-10 Finland

Other physical therapy

2.8

49.5

251

914

R42

ICD-10 Finland

Dizziness and giddiness

1.8

49.2

950

5868

L90

ICPC

Osteoarthrosis of knee

2.4

49.2

351

1512

R06AE07

ATC

cetirizine; oral

1.6

49.2

1995

14885

H02BX01

ATC

methylprednisolone, combinations; systemic

3.0

49.2

230

801

J01CA04

ATC

amoxicillin; systemic

1.7

48.9

3871

33700

M77.3

ICD-10 Finland

Calcaneal spur

5.8

48.4

153

R03BA02

ATC

budesonide; inhalant

1.8

48.1

805

4762

L14

ICPC

Leg/thigh symptom/complaint

2.3

48.0

392

1791

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.4

47.9

M77.1

ICD-10 Finland

Lateral epicondylitis

2.2

47.7

412

1927

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.8

47.4

254

952

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

47.4

478

2378

M01AB01

ATC

indometacin; systemic, rectal

2.4

47.1

331

1415

Z3226

NOMESCO Finland

Physiotherapist

1.8

47.0

773

4546

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

46.9

M77.4

ICD-10 Finland

Metatarsalgia

2.4

46.9

328

1400

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.5

46.8

302

1241

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.6

46.7

274

1075

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

46.7

850

5154

NH2AA, ,

SPAT

6.5

46.4

119

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

46.2

1087

7079

Z01.2

ICD-10 Finland

Dental examination

1.5

46.0

2188

16839

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

45.9

2139

16384

L87

ICPC

Bursitis/tendinitis/synovitis NOS

4.7

45.2

105

227

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.6

45.1

281

1135

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

73.7

45.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

44.7

1872

13981

7276F

ICD-9 Finland

Other disorders of synovium, tendon and bursa, Rupture of tendon, nontraumatic[RUPTURA NONTRAUMATICA TENDINIS ACHILLEI]

16.9

44.5

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

4.9

44.4

203

R60.0

ICD-10 Finland

Localized oedema

2.0

44.3

549

2941

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

44.3

1387

9689

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

4.0

44.2

129

333

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

43.9

345

1549

SFA20

NOMESCO Finland

Two-surface restoration

1.5

43.9

2793

22782

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

43.7

2614

21036

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

17.3

43.7

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

43.4

807

4915

NA3BG, ,

SPAT

3.1

43.2

184

607

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

43.2

1736

12823

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

43.1

298

1265

SFA10

NOMESCO Finland

One-surface restoration

1.5

42.3

2563

20627

D07AC01

ATC

betamethasone; topical

1.5

42.2

1665

12235

N06AX16

ATC

venlafaxine; oral

1.9

42.1

599

3358

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

42.0

370

1743

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.6

41.9

1472

10532

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.3

41.9

324

1445

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

148.0

41.8

A02BA02

ATC

ranitidine; systemic

1.8

41.8

755

4555

M02AA15

ATC

diclofenac; topical

2.2

41.6

356

1656

T93.5

ICD-10 Finland

Sequelae of injury of muscle and tendon of lower limb

14.2

41.6

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.4

41.4

300

1300

P01AB01

ATC

metronidazole; oral, rectal

1.5

41.4

1780

13311

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.9

41.2

199

705

M13.9

ICD-10 Finland

Arthritis, unspecified

2.3

41.2

347

1604

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.8

41.1

131

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

41.0

3095

25988

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

40.9

392

1909

M01AB08

ATC

etodolac; oral

2.3

40.9

326

1473

G54.0

ICD-10 Finland

Brachial plexus disorders

4.4

40.8

102

234

N06AX11

ATC

mirtazapine; oral

1.6

40.6

1447

10374

M77.5

ICD-10 Finland

Other enthesopathy of foot

5.9

40.0

124

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

39.7

1870

14220

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

39.7

603

3449

N02AJ13

ATC

tramadol and paracetamol; systemic

4.3

39.6

103

244

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

39.6

2078

16157

A07EC01

ATC

sulfasalazine; oral, rectal

2.3

39.6

332

1532

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.5

39.5

259

1072

UKC02

NOMESCO Finland

Cystoscopy

1.8

39.4

648

3796

R03BA08

ATC

ciclesonide; inhalant

2.1

39.3

409

2054

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

39.2

353

1676

J01MA12

ATC

levofloxacin; systemic

1.7

39.2

812

5085

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

15.6

39.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

39.1

783

4856

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.4

39.1

278

1194

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

39.1

380

1860

G04BD12

ATC

mirabegron; oral

1.9

39.0

510

2777

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

6.8

39.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

39.0

566

3190

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.3

38.9

102

243

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.0

38.8

171

576

D01BA02

ATC

terbinafine; oral

1.6

38.6

1232

8596

R05

ICPC

Cough

1.6

38.5

1092

7410

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

38.4

586

3354

L02

ICPC

Back symptom/complaint

2.1

38.4

413

2100

R20.2

ICD-10 Finland

Paraesthesia of skin

2.3

38.3

309

1402

9481

FHL

Detachment or severance of a muscle or tendon

10.9

38.2

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.9

38.1

494

2681

M09AX01

ATC

hyaluronic acid; parenteral

2.8

38.1

200

741

9102

FHL

Trepanation or removal of the local bone process

7.4

37.3

R02

ICPC

Shortness of breath/dyspnoea

1.9

37.2

550

3115

K02.1

ICD-10 Finland

Caries of dentine

1.5

37.2

2727

22546

M75.8

ICD-10 Finland

Other shoulder lesions

2.8

37.1

191

701

L12

ICPC

Hand/finger symptom/complaint

1.7

37.0

762

4758

N02AA05

ATC

oxycodone; systemic

1.7

36.9

702

4286

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.4

36.9

136

411

9476

FHL

Splitting of fascia or aponeurosis

6.7

36.9

B01AF01

ATC

rivaroxaban; oral

1.8

36.7

561

3209

SPAT1263

SPAT

Sampling

1.5

36.7

1711

12929

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

5.1

36.7

153

M19.8

ICD-10 Finland

Other specified arthrosis

2.7

36.6

204

780

NGL50, ,

NOMESCO Finland

+∞

36.5

R74

ICPC

Upper respiratory infection acute

1.5

36.4

1429

10412

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

36.3

1057

7202

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.6

36.2

122

348

S29

ICPC

Skin symptom/complaint other

1.6

36.2

916

6032

Z71.8

ICD-10 Finland

Other specified counselling

1.5

36.1

1510

11147

ACC51

NOMESCO Finland

Release of median nerve

2.2

36.1

332

1589

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

35.4

2739

22785

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

35.3

1275

9113

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

3.2

35.1

138

434

SPAT1310

SPAT

Counselling related to known health issue

1.5

35.0

1268

9068

R06AX27

ATC

desloratadine; oral

1.5

35.0

1281

9183

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.3

34.8

132

406

S76.3

ICD-10 Finland

Injury of muscle and tendon of the posterior muscle group at thigh level

3.9

34.8

102

264

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

6.9

34.7

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

34.7

298

1388

R07.3

ICD-10 Finland

Other chest pain

2.0

34.5

425

2264

S80.0

ICD-10 Finland

Contusion of knee

2.1

34.5

350

1739

WX290

NOMESCO Finland

Other blockage of nerve

1.5

34.5

2178

17402

M22.4

ICD-10 Finland

Chondromalacia patellae

3.0

34.4

153

518

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

34.4

1987

15609

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

34.3

538

3101

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

6.3

34.2

Z00.0

ICD-10 Finland

General medical examination

1.7

34.2

815

5279

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

34.2

451

2460

N05CF02

ATC

zolpidem; oral

1.7

34.1

751

4766

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.6

34.1

113

319

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

65.4

34.0

R03AC03

ATC

terbutaline; inhalant

1.8

33.9

582

3445

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

33.9

1332

9681

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

33.7

3321

28792

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

33.4

N05CF01

ATC

zopiclone; oral

1.5

33.3

1286

9308

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

33.2

588

3511

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.5

33.2

221

921

1220

FHL

Arthroscopy

2.7

33.1

185

708

AA1AD

NOMESCO Finland

CT of head and brain

1.5

33.0

1150

8137

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

32.9

390

2049

M01AC02

ATC

tenoxicam; systemic, rectal

2.5

32.9

210

858

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

32.9

289

1358

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.1

32.5

138

455

R4110

NOMESCO Finland

Physiotherapy

1.5

32.5

1202

8613

W19

ICD-10 Finland

Unspecified fall

1.9

32.3

419

2270

N06AA10

ATC

nortriptyline; systemic

4.0

32.3

229

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

32.3

737

4716

S86.3

ICD-10 Finland

Injury of muscle(s) and tendon(s) of peroneal muscle group at lower leg level

3.8

32.2

100

270

H02AB07

ATC

prednisone; oral

1.8

32.1

561

3335

L29

ICPC

Musculoskeletal sympt/complt other

2.0

32.0

378

1983

M23.8

ICD-10 Finland

Other internal derangements of knee

2.6

32.0

193

767

M76.5

ICD-10 Finland

Patellar tendinitis

5.1

32.0

133

J01DA09

ATC

[U] cefadroxil

1.5

31.6

1141

8125

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

31.4

480

2742

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

31.3

546

3244

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

31.1

1587

12111

L84

ICPC

Back syndrome without radiat pain

2.6

31.0

181

708

C08CA01

ATC

amlodipine; oral

1.5

31.0

1644

12639

E0000UV, ,

ATC

1.4

30.7

1812

14204

J01FA15

ATC

telithromycin; oral

1.9

30.6

446

2508

C09CA06

ATC

candesartan; oral

1.5

30.6

1105

7861

C07AB07

ATC

bisoprolol; oral

1.4

30.5

2002

15987

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

30.5

527

3121

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.8

30.2

154

562

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

30.2

540

3230

NHA30

NOMESCO Finland

Exploration of joint of ankle or foot, arthroscopic

6.9

30.1

M76

ICD-10 Finland

Enthesopathies of lower limb, excluding foot

6.2

30.0

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

29.8

1057

7485

N04BC05

ATC

pramipexole; oral

2.1

29.8

289

1411

73101

ICD-8 Finland

Tendinivaginitis chronica, inflammation of the synovial membrane, bursa and tendon sheath

10.4

29.8

S06.0

ICD-10 Finland

Concussion

1.9

29.7

433

2434

M01AE52

ATC

naproxen and esomeprazole; oral

2.8

29.7

148

534

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

29.7

1485

11268

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

156.0

29.7

R06AX22

ATC

ebastine; oral

1.6

29.6

761

5008

9478

FHL

Tendoraphy or reconstruction, e.g., graft, reflex, tenodesis

5.7

29.5

M35.7

ICD-10 Finland

Hypermobility syndrome

5.7

29.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

29.3

416

2319

E66

ICD-10 Finland

Obesity

2.1

29.3

277

1339

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

29.2

ZXE00

NOMESCO Finland

One hour or less

1.4

29.0

1628

12606

3051, ,

Kela drug reimbursment

4.3

29.0

173

J45

ICD-10 Finland

Asthma

1.8

28.9

443

2531

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

28.9

924

6394

R35

ICD-10 Finland

Polyuria

2.1

28.8

291

1443

H01

ICPC

Ear pain/earache

1.8

28.6

483

2838

L04AX03

ATC

methotrexate; systemic

1.9

28.6

411

2301

A02BC04

ATC

rabeprazole; oral

1.9

28.6

377

2053

M04AA01

ATC

allopurinol; systemic

1.7

28.5

524

3155

TAB20

NOMESCO Finland

Epidural puncture

9.8

28.5

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

6.1

28.4

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.0

28.4

128

437

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.0

28.4

127

432

R96

ICPC

Asthma

1.9

28.3

411

2308

K30

ICD-10 Finland

Functional dyspepsia

1.8

28.2

466

2721

N02AC04

ATC

dextropropoxyphene; oral

3.3

28.2

107

330

R52.1

ICD-10 Finland

Chronic intractable pain

8.0

28.1

ZXD20

NOMESCO Finland

Day surgery

1.7

28.1

543

3317

T82

ICPC

Obesity

2.4

28.0

203

879

NHL30

NOMESCO Finland

Suture or reinsertion of tendon of foot

5.1

28.0

114

M70.8

ICD-10 Finland

Other soft tissue disorders related to use, overuse and pressure

4.7

28.0

137

SFA30

NOMESCO Finland

Three-surface restoration

1.4

27.9

1983

15980

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

27.9

867

5955

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

27.8

420

2386

1221

FHL

Arthroscopy and meniscus surgery

2.9

27.7

133

470

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

27.7

1539

11873

EB1VA, ,

NOMESCO Finland

1.6

27.6

827

5631

J01DA06

ATC

[U] cefuroxime

1.7

27.4

608

3849

C03CA01

ATC

furosemide; systemic

1.5

27.2

1030

7376

M20.2

ICD-10 Finland

Hallux rigidus

2.7

27.2

153

588

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

27.2

1117

8133

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

27.1

495

2973

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

27.1

M15.8

ICD-10 Finland

Other polyarthrosis

3.3

27.0

101

309

NG1AA, ,

SPAT

1.8

26.9

427

2462

R21

ICPC

Throat symptom/complaint

1.6

26.8

818

5590

R5599

NOMESCO Finland

Other rehabilitation service

3.3

26.8

100

305

D19

ICPC

Teeth/gum symptom/complaint

1.4

26.8

1381

10495

M70.7

ICD-10 Finland

Other bursitis of hip

3.1

26.8

111

361

D07AD01

ATC

clobetasol; topical

1.6

26.6

741

4958

R03BA01

ATC

beclometasone; inhalant

1.7

26.6

549

3411

Z3231

NOMESCO Finland

Registered nurse

1.5

26.6

1107

8077

XKD00

NOMESCO Finland

Uroflowmetry

1.6

26.6

608

3880

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.2

26.5

242

1154

L60.0

ICD-10 Finland

Ingrowing nail

2.3

26.5

204

907

M75.2

ICD-10 Finland

Bicipital tendinitis

2.9

26.5

127

449

A98

ICPC

Health maint/preventive medicine

2.4

26.5

4753

45525

A10BJ02

ATC

liraglutide; parenteral

2.7

26.5

149

573

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

26.4

283

1433

K08.80

ICD-10 Finland

Toothache NOS

1.8

26.3

395

2240

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

29.4

26.3

R05

ICD-10 Finland

Cough

1.5

26.2

911

6401

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

26.2

168

688

C10AA05

ATC

atorvastatin; oral

1.4

26.2

1838

14735

SPAT1211

SPAT

Application of soft bandage

1.9

26.2

341

1848

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

26.2

958

6806

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.4

26.1

186

799

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

26.1

162

654

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.2

26.0

237

1130

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

25.8

953

6779

D01

ICPC

Abdominal pain/cramps general

1.7

25.6

482

2918

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

25.6

513

3159

R06AE09

ATC

levocetirizine; oral

1.6

25.6

609

3923

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

25.6

1166

8649

NBG10

NOMESCO Finland

Acromioplastia

3.1

25.5

109

361

K07.60

ICD-10 Finland

Snapping jaw

2.3

25.4

199

891

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

25.4

199

892

M15

ICD-10 Finland

Polyarthrosis

2.3

25.3

199

893

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

2.4

25.3

177

755

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

4.3

25.2

149

M77.0

ICD-10 Finland

Medial epicondylitis

2.8

25.2

130

478

TQW40, ,

SPAT

1.7

25.1

458

2748

KMAK, ,

NOMESCO Finland

1.4

24.9

2221

18469

J46

ICD-10 Finland

Status asthmaticus

2.9

24.9

118

415

N03AE01

ATC

clonazepam; systemic

2.2

24.8

214

998

J02AC02

ATC

itraconazole; systemic

1.5

24.8

776

5326

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.5

24.8

152

610

R53

ICD-10 Finland

Malaise and fatigue

1.5

24.7

948

6790

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

24.7

293

1538

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

9.1

24.7

J20

ICD-10 Finland

Acute bronchitis

1.8

24.7

431

2554

A02BA04

ATC

nizatidine; systemic

2.0

24.7

270

1378

N06AB04

ATC

citalopram; systemic

1.5

24.7

811

5625

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.2

24.7

212

987

L18

ICPC

Muscle pain

2.4

24.7

179

776

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

24.6

220

1041

M10.9

ICD-10 Finland

Gout, unspecified

2.0

24.4

292

1537

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

24.3

967

6973

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

24.4

24.3

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

24.2

891

6327

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

24.2

259

1312

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

24.0

1183

8886

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

24.0

R03AC13

ATC

formoterol; inhalant

2.2

24.0

200

920

SPAT1301

SPAT

No procedures

1.4

24.0

1142

8525

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

23.9

830

5821

C10AA07

ATC

rosuvastatin; oral

1.4

23.8

1539

12123

SPAT1229

SPAT

Assessment of need for aid

2.0

23.7

257

1308

NFL30

NOMESCO Finland

Transposition of muscle of hip or thigh

4.1

23.7

161

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.4

23.7

159

666

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

23.7

158

660

A03FA02

ATC

cisapride; oral, rectal

2.0

23.5

256

1304

R01AD59

ATC

mometasone, combinations; nasal

1.9

23.5

300

1615

A46

ICD-10 Finland

Erysipelas

1.6

23.5

612

4025

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.4

23.4

158

663

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

23.4

274

1432

J01FA01

ATC

erythromycin; systemic

1.6

23.4

538

3432

M66.5

ICD-10 Finland

Spontaneous rupture of unspecified tendon

9.7

23.2

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

23.2

2183

18232

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.9

23.2

110

387

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

23.1

192

882

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

23.0

205

968

SPAT1312

SPAT

General health counselling

1.4

23.0

1213

9212

M62.6

ICD-10 Finland

Muscle strain

2.4

23.0

153

638

R09

ICPC

Sinus symptom/complaint

1.9

23.0

319

1764

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

22.9

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

22.9

C05AA08

ATC

fluocortolone; rectal, topical

1.6

22.9

561

3633

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.8

22.8

116

424

D11

ICPC

Diarrhoea

1.7

22.7

467

2894

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

22.7

1215

9250

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

22.7

1314

10141

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

22.7

181

818

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

231.0

22.6

J01MA14

ATC

moxifloxacin; systemic

1.8

22.6

368

2136

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

22.6

999

7341

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

22.6

473

2945

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.5

22.6

227

SPAT1216

SPAT

Assessment of functional ability

1.6

22.4

513

3268

B01AX06

ATC

[U] rivaroxaban

3.2

22.4

288

C01CA24

ATC

epinephrine; parenteral

2.0

22.3

257

1335

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

3.2

22.3

273

NHM10

NOMESCO Finland

Fasciotomy of ankle or foot

6.2

22.3

R06.5

ICD-10 Finland

Mouth breathing

1.7

22.3

406

2433

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

22.3

176

791

R5110, ,

SPAT

1.8

22.3

330

1862

G04CA02

ATC

tamsulosin; oral

1.5

22.3

875

6284

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.4

22.2

153

648

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.5

22.2

136

546

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

2.4

22.2

159

686

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.6

22.1

M24.2

ICD-10 Finland

Disorder of ligament

3.7

22.0

188

WX002

NOMESCO Finland

Sedation and analgesia

1.5

22.0

768

5383

SPAT1260

SPAT

Consultation of another employee

1.6

22.0

635

4272

NH3BG

NOMESCO Finland

MRI of foot

4.8

21.9

103

OAA65, ,

SPAT

1.5

21.9

794

5608

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

+∞

21.9

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.0

21.7

259

1363

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

21.7

477

3007

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

21.7

297

1636

NA2AD

NOMESCO Finland

Thoracic spine CT examination

7.2

21.6

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.1

21.5

290

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

21.5

248

1290

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

21.4

211

1036

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.3

21.4

159

697

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

21.4

348

2020

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

21.1

3010

26582

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

21.1

211

1042

C10AC01

ATC

colestyramine; oral

2.7

21.1

115

436

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

21.0

673

4631

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.8

20.9

327

1875

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.0

20.9

311

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

20.8

385

2317

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.0

20.8

322

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

20.8

166

750

M67.4

ICD-10 Finland

Ganglion

1.8

20.8

298

1664

J01EA01

ATC

trimethoprim; systemic

1.4

20.8

929

6829

7177A

ICD-9 Finland

Internal derangement of knee, Chondromalacia of patella

3.7

20.8

177

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

20.8

418

2574

SPAT1202

SPAT

Intra-articular injection

2.7

20.7

110

411

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

20.7

193

928

M76.4

ICD-10 Finland

Tibial collateral bursitis [Pellegrini-Stieda]

4.2

20.7

133

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.3

20.7

240

NA3AA, ,

SPAT

2.3

20.7

155

682

E929A

ICD-9 Finland

Late effects of accidental injury[YLIRASITUS JA KESTOKYVYN YLIT LIIKK AIH TAPAT]

4.2

20.7

129

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

4.1

20.6

138

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.5

20.6

125

500

R31

ICD-10 Finland

Unspecified haematuria

1.7

20.5

390

2364

SDA03

NOMESCO Finland

Periodontal treatment

1.3

20.5

1842

15185

S21

ICPC

Skin texture symptom/complaint

1.5

20.5

622

4229

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.6

20.5

118

460

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

20.4

268

1456

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.0

20.4

229

1180

SGA01

NOMESCO Finland

Emergency treatment

1.5

20.4

718

5037

L04

ICPC

Chest symptom/complaint

1.9

20.3

255

1364

N39.3

ICD-10 Finland

Stress incontinence

1.9

20.3

276

1516

R03BC03

ATC

nedocromil; inhalant

1.9

20.3

282

1560

B01AE07

ATC

dabigatran etexilate; oral

2.3

20.3

155

688

R83

ICPC

Respiratory infection other

1.4

20.3

1058

7994

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

20.2

453

2869

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

20.1

320

1846

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

20.1

466

2976

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

20.1

303

1720

J05AB01

ATC

aciclovir; systemic

1.4

20.0

877

6417

N17

ICPC

Vertigo/dizziness

1.6

20.0

460

2929

R03AC12

ATC

salmeterol; inhalant

2.3

20.0

159

717

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.1

20.0

187

901

A29

ICPC

General symptom/complaint other

1.6

19.9

515

3374

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.2

19.9

169

784

N01

ICPC

Headache

1.7

19.8

380

2309

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

19.7

118

469

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

19.7

340

2008

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.9

19.6

311

C10AX09

ATC

ezetimibe; oral

1.5

19.6

723

5117

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.3

19.6

154

692

P06

ICPC

Sleep disturbance

1.6

19.5

522

3446

R13

ICD-10 Finland

Dysphagia

1.9

19.5

265

1455

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

19.5

462

2965

NH3AA, ,

SPAT

1.9

19.4

270

1493

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

19.4

593

4033

NH1AA, ,

SPAT

2.3

19.4

150

669

NG1BG, ,

SPAT

2.1

19.4

196

973

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

19.3

1614

13133

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

19.3

1409

11232

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

19.3

1177

9121

G04CA01

ATC

alfuzosin; oral

1.6

19.2

485

3159

C07AA05

ATC

propranolol; systemic

1.5

19.2

777

5597

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

19.2

219

1135

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

19.1

566

3823

H93.1

ICD-10 Finland

Tinnitus

1.8

19.1

298

1708

H92.0

ICD-10 Finland

Otalgia

1.9

19.1

247

1336

G04BD08

ATC

solifenacin; oral

1.9

19.1

231

1222

9489

FHL

Other measure in this category

18.2

19.1

J01MA01

ATC

ofloxacin; systemic

1.8

19.0

310

1799

A03

ICPC

Fever

1.5

19.0

671

4707

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

18.9

461

2977

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

18.9

236

1261

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

18.9

537

3595

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

18.7

508

3364

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

3.1

18.7

245

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

18.7

228

1209

F29

ICPC

Eye symptom/complaint other

1.6

18.6

444

2852

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

3.6

18.6

172

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.8

18.5

327

D82

ICPC

Teeth/gum disease

1.3

18.5

1607

13130

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

18.5

290

1665

M41.9

ICD-10 Finland

Scoliosis, unspecified

6.2

18.4

S97

ICPC

Chronic ulcer skin

1.9

18.4

240

1300

N41.1

ICD-10 Finland

Chronic prostatitis

2.6

18.4

103

396

NG2AA

NOMESCO Finland

Patella X-ray examination

2.4

18.4

124

521

J01

ICD-10 Finland

Acute sinusitis

1.9

18.3

224

1188

8450C

ICD-9 Finland

Sprains and strains of ankle and foot, Ankle[DISTORSIO,DISTENSIO SEU RUPTURA TENDINIS ACHILLIS]

5.8

18.3

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

18.3

540

3644

G04BD04

ATC

oxybutynin; oral, transdermal

2.1

18.2

172

832

P01BA02

ATC

hydroxychloroquine; oral

1.7

18.1

308

1809

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.3

18.1

204

R25.2

ICD-10 Finland

Cramp and spasm

2.7

18.1

100

382

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.2

18.1

160

755

C09DA06

ATC

candesartan and diuretics; oral

1.7

18.0

328

1964

M10.0

ICD-10 Finland

Idiopathic gout

2.2

18.0

148

678

SPAT1210

SPAT

Application of cast or individual aid

2.2

18.0

159

750

M25.2

ICD-10 Finland

Flail joint

3.8

17.9

139

NF1DA

NOMESCO Finland

X-ray of hips

3.0

17.9

273

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.7

17.9

339

K03.80

ICD-10 Finland

Irradiated enamel

1.9

17.9

232

1256

L20

ICPC

Joint symptom/complaint NOS

2.2

17.9

148

680

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.4

17.8

120

504

H02.3

ICD-10 Finland

Blepharochalasis

1.8

17.8

254

1417

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

17.7

263

1485

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

+∞

17.7

GD1AA, ,

SPAT

1.5

17.7

719

5177

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

17.7

184

923

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

17.7

375

2340

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.0

17.6

195

1000

M53.2

ICD-10 Finland

Spinal instabilities

36.8

17.6

U02

ICPC

Urinary frequency/urgency

1.5

17.5

541

3687

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

17.5

1078

8348

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

17.4

358

2216

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

17.4

276

1590

XF402

NOMESCO Finland

ECG with work load test

1.6

17.4

386

2437

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

17.3

1564

12820

-1, ,

NOMESCO Finland

1.3

17.3

1313

10496

NHE20

NOMESCO Finland

Plastic repair of capsule or ligament of ankle joint with transplant

6.0

17.3

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.7

17.3

345

R03BB04

ATC

tiotropium bromide; inhalant

1.7

17.2

339

2073

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1218

6447

2.18

109.77

1.4

1.3

6.13

14.41

u/ml

5.02

488

2558

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3801

30331

2.12

103.40

5.3

3.9

11.22

11.79

mm/h

1.79

3617

28409

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1268

6996

2.10

101.48

1.4

1.3

29.37

36.42

iu/ml

0.68

377

2133

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1387

8618

1.85

74.71

1.9

1.7

1.10

1.28

mg/l

1.12

1098

6694

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1760

11989

1.73

67.94

2.4

2.1

169.08

220.63

u/l

2.53

1670

11324

(3026493) Urate [Moles/volume] in Serum or Plasma

1647

11072

1.73

66.30

2.9

2.7

345.60

343.57

umol/l

0.37

1472

9932

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4594

41590

2.65

62.94

18.9

14.3

20.00

24.97

mg/l

25.35

3938

33555

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3777

32140

1.76

58.52

8.9

8.5

77.08

79.55

u/l

3.72

3618

30594

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3754

32276

1.70

51.45

4.8

4.2

14.65

14.71

pmol/l

0.71

3507

29787

(3013115) Eosinophils [#/volume] in Blood

2726

21779

1.57

49.95

7.0

6.7

0.20

0.19

e9/l

0.58

2424

18961

(3006315) Basophils [#/volume] in Blood

2647

21092

1.55

48.41

7.0

6.5

0.04

e9/l

0.09

2331

18050

(3013826) Glucose [Moles/volume] in Serum or Plasma

2943

24040

1.56

47.94

5.6

5.0

6.60

6.75

mmol/l

3.76

2820

22821

(3019198) Lymphocytes [#/volume] in Blood

2686

21513

1.55

47.69

7.1

6.5

1.97

1.91

e9/l

1.24

2406

18868

(3001604) Monocytes [#/volume] in Blood

2635

21051

1.54

47.05

7.0

6.5

0.58

0.59

e9/l

1.20

2324

18013

(3032080) INR in Blood by Coagulation assay

2365

18524

1.53

45.73

14.8

13.7

1.22

1.24

inr

0.95

1956

15353

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1722

12578

1.57

45.67

3.1

2.6

54.43

63.19

u/l

3.79

1613

11686

(3037522) Nuclear Ab [Titer] in Serum

907

5636

1.75

45.65

1.5

1.4

599.04

526.04

titre

0.43

167

1226

(3008898) HLA-B27 [Presence]

268

1069

2.59

44.18

1.1

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4300

38883

1.86

43.82

5.9

5.0

1.82

1.92

mu/l

7.39

4033

36051

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2381

18850

1.51

42.64

2.9

2.7

—

estimate

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4411

40321

1.93

41.89

7.3

6.0

39.11

39.17

mmol/mol

0.22

4193

37949

(3013512) EKG study

1886

14275

1.52

41.46

3.8

3.3

0.83

0.82

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4629

43121

2.31

40.80

21.3

17.0

3.98

3.97

mmol/l

3.34

4557

42158

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3107

26126

1.52

40.77

3.2

2.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4616

42994

2.25

39.97

21.0

16.8

139.93

139.78

mmol/l

5.09

4551

42121

(3035350) Ketones [Presence] in Urine by Test strip

2634

21466

1.49

39.82

4.3

3.4

2.90

3.92

estimate

0.13

531

4482

(3021601) Nitrite [Presence] in Urine by Test strip

2611

21252

1.49

39.64

4.3

3.4

0.01

0.00

estimate

0.77

523

4407

(3009261) Glucose [Presence] in Urine by Test strip

2646

21641

1.48

38.89

4.3

3.4

0.00

0.33

estimate

0.74

491

4196

(3013650) Neutrophils [#/volume] in Blood by Automated count

2857

23731

1.49

38.84

9.8

10.7

4.00

4.06

e9/l

0.78

2536

20497

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1541

11308

1.53

38.44

3.1

955.15

1325.37

ng/l

3.00

1291

9724

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2254

17906

1.48

38.06

2.2

2.0

99.55

96.06

pmol/l

2.82

1212

9496

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1932

14910

1.49

37.58

3.9

3.2

30.49

59.41

ng/l

3.06

1332

10001

(3031040) Bacteria [#/volume] in Urine by Automated count

3055

25843

1.48

36.97

5.2

4.0

1993.15

1338.79

e6/l

0.14

362

(3015736) pH of Urine

2140

16893

1.47

36.93

3.7

3.1

6.18

6.17

0.31

1235

9565

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2486

20229

1.46

36.53

8.0

7.6

1.21

mmol/l

0.99

2184

17452

(3022096) Basophils/Leukocytes in Blood

2412

19551

1.46

35.93

7.1

6.7

0.71

0.69

0.81

2280

18370

(3018010) Neutrophils/Leukocytes in Blood

2426

19688

1.46

35.90

7.0

6.5

56.42

57.27

3.20

2333

18862

(40768797) Stomach Pathology biopsy report

857

5573

1.65

35.51

1.3

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2641

21816

1.46

35.39

6.5

7.3

11.03

11.73

umol/l

2.12

2522

20877

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4432

40970

1.85

34.95

5.9

4.9

5.92

mmol/l

0.09

4145

37895

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2332

18864

1.45

34.62

2.7

2.4

77.22

77.17

nmol/l

0.03

2128

17253

(3002030) Lymphocytes/Leukocytes in Blood

2461

20114

1.45

34.54

7.1

6.7

28.79

27.74

5.02

2351

19108

(3019069) Monocytes/Leukocytes in Blood

2402

19572

1.45

34.09

7.1

6.8

8.78

8.92

1.64

2276

18430

(3045414) Leukocytes [Presence] in Urine

599

3576

1.77

33.89

2.4

2.0

0.01

0.02

estimate

0.53

127

765

(3006504) Eosinophils/Leukocytes in Blood

2395

19540

1.44

33.55

7.0

6.7

2.97

2.84

1.87

2261

18383

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2233

18046

1.44

32.59

7.3

6.9

1.21

mmol/l

0.16

2078

16776

(3024561) Albumin [Mass/volume] in Serum or Plasma

2254

18294

1.43

31.87

5.3

5.5

36.47

35.74

g/l

9.08

2136

17226

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4747

45253

2.52

30.14

23.6

18.7

78.08

77.23

umol/l

1.05

4713

44756

(3048689) Calprotectin [Mass/mass] in Stool

751

4910

1.63

30.01

2.3

2.5

125.93

136.05

ug/g

0.42

607

3941

(3007853) Bacteria identified in Skin by Aerobe culture

713

4607

1.64

29.86

2.0

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4532

42525

1.86

29.24

5.7

5.0

1.43

1.47

mmol/l

8.19

4293

39836

(3042936) Bacteria identified in Isolate by Culture

847

5733

1.58

29.20

2.3

2.1

—

(3044889) 12 lead EKG panel

3404

29992

1.44

29.04

4.4

3.7

0.25

5456.82

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4371

40608

1.70

28.98

4.8

4.2

1.36

1.30

mmol/l

6.26

4113

37708

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4548

42743

1.88

28.89

5.8

5.0

4.63

4.70

mmol/l

4.94

4326

40278

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4428

41316

1.74

28.45

17.1

14.3

81.26

82.03

ml/min/173m2

2.00

4149

38030

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4584

43261

1.91

27.69

6.6

5.6

2.71

2.77

mmol/l

4.70

4352

40606

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2321

19237

1.39

27.55

3.5

3.0

127.23

137.67

ug/l

0.89

2175

18083

(3005322) IgE [Units/volume] in Serum or Plasma

436

2518

1.80

27.37

1.5

1.3

224.83

255.08

u/ml

0.23

412

2344

(3015171) Extractable nuclear Ab [Units/volume] in Serum

286

1445

2.04

26.89

1.3

1.2

0.18

1.28

u/ml

2.54

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4714

44994

2.22

26.56

14.1

11.6

27.94

27.10

u/l

2.39

4608

43765

(3035941) MCH [Entitic mass]

4806

46334

2.85

25.22

27.9

21.9

30.40

30.35

1.18

4780

45851

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4806

46335

2.84

25.20

27.9

22.0

91.13

91.07

0.41

4780

45852

(3007461) Platelets [#/volume] in Blood

4805

46321

2.83

25.19

28.0

22.0

251.53

251.23

e9/l

0.12

4755

45371

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4806

46339

2.84

25.12

28.5

22.5

41.99

41.35

0.28

4779

45830

(3026361) Erythrocytes [#/volume] in Blood

4806

46339

2.84

25.12

28.0

22.0

4.56

4.53

e12/l

5.51

4748

45223

(3010813) Leukocytes [#/volume] in Blood

4806

46347

2.83

24.95

28.0

22.1

6.71

6.61

e9/l

1.30

4747

45230

(3000963) Hemoglobin [Mass/volume] in Blood

4806

46351

2.83

24.87

28.2

22.2

137.82

136.57

g/l

8.14

4782

45874

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1968

16082

1.37

24.45

4.1

3.3

0.01

0.06

estimate

1.03

426

3599

(3019150) Specific gravity of Urine by Refractometry

1179

8842

1.44

24.16

4.3

3.5

2.28

1.02

kg/l

0.50

799

5786

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

451

2727

1.72

24.05

2.6

2.4

20.49

21.96

au/ml

0.15

357

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1200

9037

1.43

24.01

1.3

1.36

2.11

u/ml

1.80

309

2446

(3021960) Folate [Moles/volume] in Serum or Plasma

1423

11073

1.40

23.57

1.8

1.6

20.33

20.09

nmol/l

0.25

1209

9419

(3000475) Leukocytes [#/volume] in Synovial fluid

197

907

2.22

23.57

1.8

1.5

7616.69

13181.85

e6/l

2.05

142

620

(40768804) Tissue Pathology biopsy report

2116

17569

1.36

23.44

2.2

2.1

—

(3012516) Albumin [Mass/volume] in Urine

1746

14092

1.37

23.05

3.6

3.5

41.12

49.60

mg/l

0.97

1101

9009

(3009508) Creatinine [Moles/volume] in Urine

1833

14924

1.36

22.84

3.4

3.5

7.98

7.75

mmol/l

1.38

1572

12680

(3020682) Albumin/Creatinine [Ratio] in Urine

1770

14358

1.36

22.48

4.2

7.33

8.94

mg/mmol

0.80

1103

8994

(3000850) Epithelial cells [#/volume] in Urine

1145

8664

1.42

22.01

3.0

2.6

4.84

5.63

e6/l

1.35

1043

7901

(3017732) Neutrophils [#/volume] in Blood

742

5175

1.51

21.76

2.8

3.5

4.60

4.33

e9/l

0.38

643

4533

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3336

29880

1.36

21.62

3.7

3.2

48.75

48.26

u/l

0.12

3145

28221

(40758558) Short blood count panel - Blood

1573

12643

1.36

20.77

6.2

6.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

410

2512

1.69

20.76

1.4

1.3

48.71

54.66

au/ml

0.23

190

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1021

7638

1.43

20.76

4.3

3.5

184.77

625.09

ng/l

2.54

775

5885

(3002582) Erythrocytes [#/volume] in Urine

1612

13012

1.36

20.69

4.1

3.2

44.54

79.31

e6/l

1.33

1270

9699

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1274

9918

1.38

20.50

2.6

2.3

2.84

2.78

mg/l

0.36

1103

8568

(3044640) Blood type and Crossmatch panel - Blood

1618

13097

1.35

20.29

2.5

—

(3018095) Leukocytes [#/volume] in Urine

1819

14990

1.34

20.22

4.8

3.7

70.20

99.39

e6/l

1.33

1328

10337

(3014051) Protein [Presence] in Urine by Test strip

1481

11831

1.36

20.22

3.1

2.7

0.00

0.05

1.92

256

(3030467) Casts [#/volume] in Urine by Automated count

1408

11222

1.36

19.33

3.8

3.1

0.33

0.42

e6/l

0.99

1063

7973

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1267

9972

1.36

18.75

2.5

2.4

—

(3026008) Bacteria identified in Urine by Culture

1378

11016

1.35

18.36

3.3

2.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1721

14225

1.32

18.21

3.3

3.9

2.35

mmol/l

0.07

1572

13032

(3021589) Normoblasts [#/volume] in Blood

2215

18963

1.31

18.14

11.9

11.2

0.00

e9/l

0.24

1845

15426

(40760892) CBC W Ordered Manual Differential panel - Blood

1203

9443

1.36

17.98

4.8

4.7

—

(3000494) Fungus identified in Specimen by Culture

717

5156

1.46

17.78

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1049

8081

1.38

17.58

1.5

2.32

2.44

g/l

1.27

637

5136

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

615

4308

1.49

17.41

7.8

5.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

847

6304

1.42

17.38

2.2

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

189

964

2.00

17.35

1.2

1.1

3.83

4.01

0.11

145

(3030981) Hyaline casts [#/volume] in Urine by Automated count

480

3192

1.56

17.34

2.9

2.4

0.26

0.46

e6/l

2.44

454

3048

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1757

14642

1.31

17.29

3.2

3.4

32.42

37.53

u/l

1.50

1651

13838

(3018418) pH of Serum or Plasma

1475

11999

1.33

17.23

4.8

4.5

7.40

0.11

1064

8449

(3017446) Testosterone [Moles/volume] in Serum or Plasma

560

3861

1.51

17.12

2.8

2.3

13.44

13.86

nmol/l

0.61

505

3550

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2198

18891

1.30

17.11

2.0

1.9

1.42

1.37

mmol/l

1.48

1841

15878

(3029937) Albumin [Presence] in Urine by Test strip

1408

11407

1.33

16.85

4.5

3.5

0.00

estimate

2.46

504

4021

(3036481) Cortisol [Moles/volume] in Serum or Plasma

541

3715

1.51

16.85

2.2

2.4

356.13

384.81

nmol/l

2.44

497

3465

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

298

1782

1.72

16.47

2.1

38.82

39.56

u/l

0.27

269

1602

(3023420) DNA double strand Ab [Units/volume] in Serum

278

1633

1.74

16.38

1.7

1.8

6.78

7.44

iu/ml

0.14

381

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

192

1008

1.94

16.23

1.6

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

924

7062

1.38

16.09

3.5

2.8

1.01

1.11

e6/l

0.27

555

3595

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

447

2981

1.55

15.91

1.5

1.4

—

(3045424) Erythrocytes [Presence] in Urine

310

1892

1.68

15.89

2.3

2.1

0.10

0.01

estimate

0.42

105

598

(3025941) Bacteria identified in Stool by Culture

327

2034

1.65

15.58

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

408

2680

1.57

15.52

1.2

—

(3022145) Colonoscopy Study observation

676

4950

1.42

15.04

1.3

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

634

4606

1.43

14.72

2.1

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

430

2906

1.53

14.38

4.3

4.4

90.15

95.70

ng/l

0.56

384

2525

(3047007) Chlamydophila sp Ab [Presence] in Serum

118

559

2.14

13.29

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

203

1159

1.78

13.23

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

205

1175

1.78

13.19

1.8

1.7

0.23

0.24

g/l

0.46

197

1123

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

210

1221

1.75

12.87

1.7

1.23

1.20

g/l

0.63

202

1171

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

112

527

2.15

12.84

1.1

3.33

3.01

0.11

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

197

1125

1.78

12.84

2.2

1.8

200.26

207.47

pmol/l

0.48

191

1073

(3044941) Cell count panel - Synovial fluid

131

657

2.02

12.70

1.5

1.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

399

2.30

12.39

1.6

56.54

57.97

0.11

258

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

198

1149

1.75

12.23

1.4

1.3

7.66

6.68

u/ml

0.08

185

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

198

1150

1.75

12.19

1.3

3.51

2.91

u/ml

0.13

106

(3019309) Folate [Moles/volume] in Red Blood Cells

777

6020

1.35

12.08

1.7

1124.36

1130.16

nmol/l

0.06

599

4570

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3776

35412

1.29

12.07

21.3

18.2

13.59

13.58

0.32

3741

34924

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

834

6531

1.33

12.07

3.8

3.0

3.27

2.37

e6/l

1.06

458

3049

(3009343) pH of Capillary blood

376

2564

1.51

12.03

3.6

7.41

7.42

1.12

309

2121

(3019225) pH of Specimen

522

3796

1.42

11.96

4.2

4.3

7.36

0.13

372

2751

(3022948) Iron [Moles/volume] in Serum or Plasma

874

6899

1.32

11.95

2.9

2.7

13.52

13.38

umol/l

0.25

826

6504

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

586

4350

1.39

11.92

2.2

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

429

3015

1.46

11.81

2.4

2.2

6.13

9.25

ug/l

2.89

380

2710

(3022313) Gas panel - Capillary blood

282

1819

1.58

11.61

3.8

3.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

122

617

2.00

11.59

1.2

1.1

24.36

14.80

au/ml

0.40

178

(3022621) pH of Urine by Test strip

442

3141

1.45

11.48

2.6

2.4

6.05

6.03

0.20

276

2071

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

382

2639

1.49

11.47

3.6

5.13

5.14

kpa

0.06

364

2536

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1687

14522

1.25

11.46

6.0

5.2

3.33

2.53

ug/l

0.43

1563

13238

(40768443) Skin Pathology biopsy report

290

1899

1.56

11.19

1.3

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

282

1835

1.57

11.19

1.7

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

205

1237

1.69

11.03

1.3

8.13

39.49

u/ml

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

969

7840

1.29

10.96

2.8

3.2

2.44

2.45

mmol/l

1.14

857

7077

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

290

2.43

10.87

1.5

1.4

3.52

1.86

u/ml

0.42

159

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

454

3278

1.42

10.80

2.9

2.6

68.81

66.90

ml/min/173m2

0.54

213

1332

(3041096) Erythrocytes [Presence] in Urine by Automated

1398

11849

1.25

10.75

3.4

3.0

0.12

estimate

0.02

429

3448

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

142

776

1.85

10.75

1.9

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

270

1756

1.57

10.74

1.9

1.6

9.29

14.22

iu/ml

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

327

2219

1.51

10.72

3.3

3.4

1.17

1.77

mmol/l

2.30

229

1653

(3003327) Ova and parasites identified in Stool by Light microscopy

223

1386

1.64

10.71

1.6

1.7

—

(4024509) Urine culture

262

1694

1.58

10.69

1.9

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

224

1398

1.63

10.59

3.7

24.71

24.82

mmol/l

0.24

206

1292

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

388

2741

1.45

10.39

1.8

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

166

968

1.74

10.14

1.2

1.48

3.83

u/ml

0.57

(3003329) Lymphocytes/Leukocytes in Synovial fluid

289

2.37

10.02

1.5

1.4

26.10

31.10

0.44

169

(3004789) Transferrin [Mass/volume] in Serum or Plasma

807

6446

1.30

9.98

2.9

2.6

2.37

2.31

g/l

2.64

755

5997

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1365

11627

1.24

9.88

4.7

4.1

21.66

21.95

0.31

659

5558

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

190

2.70

9.87

1.7

1.6

5.47

5.97

u/l

0.40

166

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

218

1377

1.61

9.84

2.2

2.4

442.64

650.92

ug/l

0.47

205

1318

(3016502) Oxygen saturation in Arterial blood

548

4150

1.36

9.80

8.2

9.1

95.84

95.75

0.15

536

4015

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

156

903

1.75

9.79

1.3

1.2

60.58

43.10

u/ml

0.57

(3023368) Bacteria identified in Blood by Culture

1294

10971

1.24

9.75

5.0

4.4

—

(36660697) Celiac disease serology panel - Serum

436

3185

1.40

9.70

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

668

5225

1.32

9.60

5.6

4.8

31.62

32.11

0.60

471

3523

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

229

1475

1.58

9.53

1.4

1.3

—

(3049717) Cytology report of Urine Cyto stain

224

1436

1.59

9.51

2.6

2.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

437

3207

1.40

9.47

2.8

2.7

66.24

66.47

g/l

0.27

397

2986

(3014765) Yersinia sp identified in Stool by Organism specific culture

158

928

1.73

9.43

1.2

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

171

1028

1.69

9.38

1.3

—

9.56

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

157

923

1.72

9.35

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

276

1864

1.51

9.28

2.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

158

934

1.71

9.23

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

288

1965

1.49

9.22

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

186

1150

1.64

9.17

2.4

2.1

11.45

11.91

mg/l

0.34

177

1088

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

119

650

1.85

9.08

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

521

3966

1.35

8.99

2.8

2.4

197.81

52.34

u/l

0.43

443

3415

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

415

2.07

8.98

1.6

2.1

26.90

24.54

mg/l

0.14

154

(3026782) Osmolality of Urine

918

7547

1.27

8.95

3.3

2.8

543.71

537.42

mosm/kgh2o

0.38

808

6634

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

745

5972

1.29

8.90

3.0

2.7

22.95

23.38

0.41

693

5604

(3033658) Prothrombin time (PT) actual/Normal

1267

10812

1.23

8.84

4.3

4.2

91.54

90.33

1.03

1235

10612

(3010144) Erythrocytes [#/volume] in Synovial fluid

313

2.22

8.79

1.4

34654.68

127961.45

e6/l

1.44

209

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

162

985

1.67

8.55

1.1

4.54

9.64

eliau/ml

0.91

143

(3027801) Oxygen [Partial pressure] in Arterial blood

597

4679

1.31

8.42

8.2

8.6

12.10

12.77

kpa

2.51

580

4519

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

597

4683

1.31

8.37

8.2

8.6

5.15

5.10

kpa

0.63

581

4523

(3003396) Base excess in Arterial blood by calculation

593

4652

1.31

8.30

8.1

8.6

1.31

0.81

mmol/l

2.60

515

3852

(3005719) IgG [Mass/volume] in Serum or Plasma

432

3234

1.37

8.30

2.8

9.85

10.65

g/l

4.41

397

3003

(3019977) pH of Arterial blood

596

4682

1.31

8.26

8.4

8.6

7.42

0.87

331

2483

(3002173) Hemoglobin [Mass/volume] in Arterial blood

508

3905

1.34

8.20

9.0

9.6

125.05

121.28

g/l

3.56

501

3819

(3012095) Magnesium [Moles/volume] in Serum or Plasma

857

7059

1.26

8.16

3.6

3.8

0.81

0.82

mmol/l

0.67

797

6710

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

114

637

1.81

8.13

1.1

124.37

116.39

1.96

585

(3004716) Salmonella sp identified in Stool by Organism specific culture

259

1782

1.48

7.99

1.3

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

178

1129

1.60

7.96

1.6

1.4

260.48

272.02

ug/g

0.33

103

676

(4195642) Thrombophilia screening test

112

628

1.80

7.91

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1058

8978

1.23

7.63

3.5

3.1

0.69

0.77

ug/l

2.45

691

5651

(3010838) Calcium [Moles/time] in 24 hour Urine

123

723

1.72

7.41

2.4

1.9

5.53

5.20

mmol/24h

0.48

109

653

(3009214) Lutropin [Units/volume] in Serum or Plasma

169

1080

1.58

7.35

1.5

1.4

8.22

10.94

u/l

2.42

137

868

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

504

1.86

7.35

1.2

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1459

1.50

7.13

2.7

2.3

2.80

2.91

g/l

0.90

196

1351

(3000330) Specific gravity of Urine by Test strip

269

1912

1.43

7.03

3.8

3.0

1.02

ratio

0.05

245

1748

(3024522) Salmonella sp identified in Specimen by Organism specific culture

499

1.84

6.96

1.2

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

222

1527

1.48

6.90

1.6

16.89

15.63

u/ml

0.08

425

(3024980) IgG subclass 4 [Mass/volume] in Serum

118

701

1.70

6.87

1.8

1.6

0.61

0.87

g/l

2.49

103

553

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

115

679

1.71

6.85

1.2

1.74

3.17

u/ml

1.60

228

(3023520) Reticulocytes [#/volume] in Blood

445

3454

1.32

6.72

2.8

69.70

70.39

e9/l

0.16

331

2513

(44816559) Phosphatidylethanol [Mass/volume] in Blood

252

1786

1.43

6.71

1.6

0.25

0.31

mg/l

1.13

111

853

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1545

1.46

6.69

2.6

2.2

4.16

4.23

g/l

0.70

204

1437

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1547

1.46

6.65

2.6

2.2

7.37

7.31

g/l

0.22

204

1438

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

382

2908

1.34

6.60

3.0

2.8

156.89

191.53

ng/l

1.14

352

2649

(3002256) Pathology report gross observation

721

5967

1.24

6.50

1.4

1.3

—

(3019060) Gas panel - Arterial blood

304

2239

1.38

6.49

5.6

5.3

—

(3024263) Appearance of Synovial fluid

183

2.36

6.45

2.1

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

497

1.81

6.45

1.2

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

456

3573

1.30

6.43

2.2

2.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

463

3641

1.30

6.36

7.7

8.7

1.31

1.32

mmol/l

0.04

452

3571

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

313

2332

1.37

6.23

2.1

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

220

1545

1.44

6.18

2.6

2.2

3.69

3.77

g/l

0.42

201

1437

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

369

1.91

6.09

1.3

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

151

2.46

6.09

1.4

5.83

2.94

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

261

1895

1.40

6.09

1.1

14.10

2.61

u/ml

—

(3012544) pH of Venous blood

510

4088

1.28

6.04

5.1

4.1

7.38

0.63

272

2342

(3014007) Fractional oxyhemoglobin in Arterial blood

354

2702

1.33

6.03

9.1

10.9

94.22

94.08

0.20

354

2693

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

353

2694

1.33

6.01

9.1

10.8

1.30

1.27

0.22

353

2675

(3005988) Vibrio sp identified in Specimen by Organism specific culture

479

1.79

6.00

1.2

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

500

4003

1.28

5.98

5.0

4.2

5.87

5.78

kpa

1.10

485

3900

(3008152) Bicarbonate [Moles/volume] in Arterial blood

311

2332

1.36

5.96

8.5

7.4

24.93

24.44

mmol/l

1.75

304

2234

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

577

1.71

5.95

1.2

2.43

7.17

u/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

347

2646

1.34

5.95

3.4

3.6

4.58

4.50

pmol/l

0.77

309

2408

(3027945) Reticulocytes/Erythrocytes in Blood

557

4524

1.26

5.91

2.8

1.76

1.80

0.46

486

4072

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

579

1.71

5.88

1.2

1.3

0.56

6.31

nmol/l

0.93

563

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

970

8356

1.20

5.84

1.8

1.7

7721022.62

28877357.98

pmol/l

1.52

816

7061

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

167

2.35

5.80

1.1

95.41

94.71

0.04

139

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

610

5017

1.25

5.80

2.5

2.9

6.52

9.00

umol/l

3.91

542

4448

(3025468) Yersinia sp identified in Specimen by Organism specific culture

477

1.77

5.80

1.2

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

452

3588

1.29

5.78

4.6

4.4

0.78

0.72

0.13

137

1119

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

478

1.77

5.76

1.2

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

797

6747

1.22

5.75

1.9

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

149

982

1.53

5.75

1.2

1.3

558.81

533.04

mg/l

0.24

140

941

(3011985) Renin [Units/volume] in Plasma

103

623

1.67

5.68

1.2

1.5

82.55

63.42

mu/l

0.37

562

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

118

740

1.61

5.65

1.4

1.3

145.00

409.49

titre

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

660

5496

1.23

5.59

7.3

6.8

1.03

mmol/l

0.29

619

5167

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

229

2.11

5.54

1.1

0.54

15.22

nmol/l

1.38

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

225

1621

1.41

5.52

2.4

1.9

2.48

2.34

ug/l

0.06

201

1478

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3742

35911

1.18

5.45

23.2

18.4

332.86

332.62

g/l

0.77

3729

35727

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

480

1.74

5.41

1.2

1.3

—

nmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

565

4644

1.24

5.40

1.8

1.7

—

(3025159) Blasts/Leukocytes in Blood

456

3656

1.27

5.40

5.0

4.8

0.79

0.48

0.18

121

981

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

199

1409

1.43

5.39

2.1

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

333

2563

1.32

5.37

1.7

2.0

1.31

1.41

g/l

0.27

305

2373

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

496

1.73

5.37

1.2

1.3

0.19

0.23

nmol/l

0.48

393

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

339

2617

1.32

5.36

9.3

11.0

0.60

0.62

0.54

339

2597

(3017181) Myelocytes/Leukocytes in Blood

469

3778

1.27

5.34

4.8

4.6

0.85

1.03

0.78

139

1191

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

170

1172

1.47

5.31

1.7

1.5

7.06

16.60

iu/ml

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

491

1.72

5.28

1.1

106.51

96.91

2.42

463

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

411

3267

1.28

5.22

2.1

1.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

192

1362

1.43

5.16

2.8

2.3

0.53

0.90

g/l

1.05

171

1171

(40759836) Histone Ab [Presence] in Serum by Immunoblot

319

1.89

5.15

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

465

1.73

5.14

1.1

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

594

1.65

5.14

1.3

0.11

0.25

nmol/l

—

(3020891) Body temperature

234

1720

1.38

5.12

5.1

4.6

36.92

36.91

°c

0.18

234

1701

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

355

2778

1.30

5.09

1.2

80.14

148.54

u/ml

5.02

119

1066

(4146454) Self-monitoring of blood glucose

437

1.75

5.07

2.6

2.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

179

1258

1.44

5.07

3.2

3.3

36.18

53.97

mg/l

0.98

160

1046

(3034860) Kappa light chains.free [Mass/volume] in Serum

179

1258

1.44

5.07

3.2

3.3

47.01

55.47

mg/l

0.51

161

1042

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

190

1350

1.42

5.07

2.6

2.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

146

2.34

5.07

1.1

1.9

40.20

40.43

g/l

0.09

146

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.90

5.02

1.4

1.2

331.52

88.48

mg/l

0.43

(3002032) Base excess in Venous blood by calculation

480

3909

1.25

4.99

5.1

4.2

2.16

1.68

mmol/l

2.20

436

3412

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

316

1.88

4.97

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

367

1.81

4.94

2.4

2.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.01

4.93

1.1

0.02

u/ml

0.20

(3021440) Promyelocytes/Leukocytes in Blood

447

3617

1.26

4.91

4.8

4.6

0.14

0.11

0.24

117

1032

(3004616) Nuclear Ab [Presence] in Serum

525

1.67

4.89

1.4

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

510

4206

1.24

4.73

3.3

3.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

211

1547

1.38

4.72

2.2

1.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

411

1.74

4.66

1.7

1.3

6.41

6.97

g/l

0.90

297

(3024139) IgG subclass 3 [Mass/volume] in Serum

411

1.74

4.66

1.7

1.3

0.37

0.44

g/l

1.85

299

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

316

1.85

4.65

1.2

—

(3036489) Thrombin time

221

1638

1.37

4.63

1.8

2.0

20.25

21.14

2.38

181

1457

(3028192) IgG subclass 2 [Mass/volume] in Serum

412

1.73

4.63

1.7

1.3

2.80

3.07

g/l

0.87

300

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

580

1.62

4.62

1.2

1.3

426.42

534.13

pmol/l

0.20

498

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.76

4.60

1.0

1.1

0.63

2.20

u/ml

0.64

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

324

2541

1.29

4.59

8.6

10.6

24.75

24.18

mmol/l

2.64

319

2497

(44790048) Parainfluenza type 2 nucleic acid detection

528

1.64

4.56

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

528

1.64

4.56

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

528

1.64

4.56

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

528

1.64

4.56

1.6

1.5

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1.80

4.42

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

404

3273

1.26

4.41

4.0

3.3

4.76

4.66

kpa

0.38

390

3187

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

127

860

1.49

4.40

1.2

1.4

26.44

24.41

e6/l

0.06

611

(3013166) Neutrophils/Leukocytes in Synovial fluid

2.62

4.39

1.2

1.3

63.30

54.52

0.46

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

128

869

1.49

4.38

1.3

1.5

1864.96

1121.56

e6/l

0.29

101

668

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

575

4841

1.21

4.37

4.6

5.0

238.80

242.64

u/l

0.27

541

4630

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

238

1.94

4.33

1.1

1.2

1.10

1.07

ratio

0.77

202

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

154

1088

1.43

4.30

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

178

2.09

4.25

1.6

1.3

152.11

134.85

nmol/l

1.14

178

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

152

1074

1.43

4.24

1.6

1.7

—

(3000991) Gas panel - Venous blood

435

3570

1.24

4.24

9.7

10.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

290

1.84

4.23

1.1

14.09

17.44

u/ml

0.49

132

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

227

1.95

4.19

2.1

76.75

116.41

ng/l

3.30

227

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

402

1.70

4.18

1.7

1.9

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

4.81

4.18

1.0

0.11

0.56

u/ml

—

(4268621) Lupus anticoagulant assay

487

1.63

4.15

2.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

264

2045

1.31

4.13

1.4

26.76

32.72

iu/l

2.38

237

1759

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

307

1.80

4.13

1.2

—

(4062490) Immunoglobulin typing, IgG

404

1.69

4.12

1.8

1.3

—

(1002224) Polysomnography panel

298

2350

1.29

4.08

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

428

1.67

4.08

1.6

1.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

168

2.09

4.06

1.5

1.8

1.02

1.51

u/ml

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.57

4.04

1.5

1.6

0.42

0.40

ug/l

0.08

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

347

1.74

4.01

1.8

361.23

368.17

mu/l

0.04

278

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

118

804

1.48

4.00

1.7

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

548

1.58

3.97

1.0

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

138

971

1.43

3.97

4.5

4.6

3.88

3.92

mmol/l

0.46

138

962

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

215

1630

1.33

3.94

1.8

4.70

4.41

mg/l

0.09

176

1199

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

558

1.57

3.91

1.1

4.48

3.38

eliau/ml

0.19

284

(3009015) Lactate [Moles/volume] in Synovial fluid

3.79

3.88

1.6

1.3

4.63

6.11

mmol/l

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

313

2502

1.27

3.86

4.0

3.4

132.24

129.54

g/l

1.24

298

2433

(3014271) Vancomycin [Susceptibility]

132

2.20

3.85

3.4

2.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

172

1266

1.37

3.82

1.5

1.6

0.02

1.17

iu/ml

0.87

215

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

345

1.72

3.81

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

345

1.72

3.81

1.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

345

1.72

3.81

1.6

1.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

309

1.76

3.76

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

124

865

1.44

3.75

1.2

1.3

3.83

3.79

mmol/l

0.18

117

819

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

250

1950

1.30

3.75

2.2

2.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

573

1.55

3.72

7.9

6.6

12.12

11.41

mg/l

0.80

538

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

100

672

1.50

3.66

1.2

2.98

4.08

u/ml

1.04

307

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

122

2.22

3.66

1.3

1.2

0.29

0.31

g/l

1.07

(4094501) Cardiovascular stress test using bicycle ergometer

170

1259

1.36

3.65

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.12

3.64

1.2

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

160

1174

1.38

3.64

3.1

2.2

0.02

g/l

0.09

149

1051

(3036670) Protein [Mass/volume] in Synovial fluid

2.38

3.64

1.7

1.2

38.54

40.31

g/l

0.23

(4015189) Microbial culture of sputum

2.61

3.63

2.4

1.9

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

276

1.78

3.61

1.6

1.4

74.65

82.86

umol/l

1.39

276

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

146

1058

1.39

3.59

3.2

2.2

0.00

g/l

-0.00

139

998

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

154

1127

1.38

3.57

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

155

1138

1.37

3.53

3.2

3.85

3.40

ratio

0.12

607

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

361

1.67

3.52

2.3

2.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

517

1.56

3.52

2.5

2.6

1.17

1.42

g/24h

0.38

320

(3052851) Hemolysis interference index of Serum or Plasma

143

1037

1.39

3.51

3.3

1.57

2.19

index

0.80

551

(3018333) Ribosomal P Ab [Presence] in Serum

301

1.74

3.51

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

558

1.53

3.49

1.3

1.4

26.97

33.45

u/l

0.91

459

(3018677) aPTT in Platelet poor plasma by Coagulation assay

728

6382

1.17

3.48

2.3

2.2

29.40

29.71

0.71

704

6204

(44813793) Dust mix specific IgE antibody measurement

243

1.82

3.47

1.1

—

(3023419) Bacteria identified in Sputum by Culture

506

1.55

3.39

2.6

2.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

383

3182

1.22

3.37

1.4

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

5.01

3.37

1.6

1.4

272.00

381.61

umol/24h

—

(3026389) Candida sp identified in Specimen by Organism specific culture

500

1.55

3.33

1.5

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

131

948

1.39

3.28

1.6

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

178

1352

1.33

3.28

2.9

2.2

9.90

10.35

g/l

0.77

157

1233

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

207

1606

1.30

3.27

2.0

1.9

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

338

0.38

3.22

14.8

14.5

574.62

4679.25

nmol/l

0.55

327

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

351

0.40

3.19

15.0

20.0

1016.00

1462.34

nmol/l

1.71

341

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

150

2.01

3.19

1.2

1.1

88.83

252.94

ng/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

666

5839

1.16

3.19

1.7

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

387

1.61

3.19

1.1

—

96.68

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

153

1142

1.35

3.18

3.1

2.2

0.00

g/l

-0.00

139

999

(3024891) Influenza virus A+B Ag [Presence] in Specimen

149

1111

1.35

3.12

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

116

830

1.41

3.12

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

252

1.75

3.11

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

615

5375

1.16

3.07

1.7

1.8

1.44

1.43

0.07

531

4761

(3003740) Influenza virus B Ag [Presence] in Specimen

116

833

1.40

3.06

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

108

767

1.42

3.04

1.4

1.3

20.61

30.66

u/l

0.75

658

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

707

6250

1.15

3.03

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

129

946

1.37

3.01

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

357

1.60

2.92

1.0

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

192

1.83

2.87

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

163

1251

1.31

2.84

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

483

4170

1.18

2.82

2.4

0.22

0.21

g/l

1.21

464

3920

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

118

864

1.37

2.81

1.1

2.08

2.27

u/ml

0.10

422

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

238

1.73

2.80

1.4

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

182

1421

1.29

2.79

2.0

2.2

99.65

92.54

4.77

173

1380

(3003888) Timothy IgE Ab [Units/volume] in Serum

105

756

1.40

2.76

1.1

5.24

4.23

u/ml

0.24

371

(4035726) Immunohistochemistry procedure

360

4248

0.84

2.76

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

240

1.71

2.73

1.4

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

119

2.02

2.65

1.5

9.22

8.84

ug/l

0.23

119

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

3.15

2.64

1.5

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

102

738

1.39

2.63

1.7

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

101

732

1.39

2.58

1.1

3.19

1.24

u/ml

0.57

290

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

130

981

1.33

2.58

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

275

1.64

2.58

1.2

1.1

35.01

44.76

mg/l

0.97

225

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

338

1.57

2.56

1.2

103.96

113.91

pmol/l

0.67

338

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

284

1.63

2.54

2.2

2.4

18.04

17.71

nmol/l

0.12

266

(3011897) Casein IgE Ab [Units/volume] in Serum

2.50

2.52

1.4

1.1

0.05

0.10

u/ml

0.34

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

652

1.40

2.50

1.7

1.4

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

3.47

2.48

2.0

1.5

1.44

1.67

mg/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

271

1.63

2.46

1.0

1.1

3.25

8.20

iu/ml

2.72

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.46

2.44

1.1

1.2

0.59

0.71

umol/24h

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

5.00

2.40

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.12

2.36

1.1

—

(40762814) Titanium [Mass/volume] in Blood

2.61

2.35

3.3

2.5

2.60

4.92

ug/l

—

(1761868) Lipid panel - Serum or Plasma

1967

18652

1.09

2.34

3.2

3.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.15

2.34

1.2

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

448

3907

1.16

2.34

8.8

8.5

9.74

mmol/l

0.00

436

3751

(3035320) C reactive protein [Mass/volume] in Body fluid

299

1.58

2.32

2.4

16.78

30.04

mg/l

3.22

211

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

184

1.74

2.31

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

184

1.74

2.31

1.3

1.6

1.25

3.56

u/field

1.46

130

(4027681) Cerebrospinal fluid IgG ratio and IgG index

200

1.70

2.27

1.2

0.51

0.66

ratio

1.32

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

366

1.51

2.24

1.1

1.0

275.91

286.75

mg/l

0.59

338

(3010726) Horse dander IgE Ab [Units/volume] in Serum

709

1.36

2.23

1.1

3.48

1.43

u/ml

0.84

320

(3002619) Bacteria identified in Specimen by Culture

2.10

2.22

1.2

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

5.56

2.21

1.0

1.1

0.02

0.03

u/ml

—

(3020650) Glucose [Presence] in Urine

157

1.79

2.21

2.0

1.4

0.11

0.04

estimate

0.27

157

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

121

1.91

2.20

1.4

1.2

—

(3037756) Immunofixation for Serum or Plasma

103

772

1.34

2.19

1.9

1.7

—

(3034426) Prothrombin time (PT)

143

1.82

2.18

1.2

26.15

28.33

2.08

143

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

155

1230

1.27

2.17

1.4

1.3

226.09

223.41

miu/ml

0.03

563

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

410

1.47

2.16

1.3

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

188

1.71

2.16

1.7

1.2

160.38

167.72

mmol/24h

0.16

188

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

129

1.86

2.16

1.4

1.7

14.39

16.30

pmol/l

0.72

112

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.62

2.14

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.21

2.10

1.3

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

3.20

2.09

1.9

1.6

—

(3037121) Protein [Mass/volume] in Urine

169

1362

1.25

2.09

3.3

3.6

294.01

479.14

mg/l

1.22

654

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

5.00

2.07

1.0

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

163

1314

1.25

2.02

2.3

2.5

190.14

195.06

0.27

146

1258

(3023511) Choriogonadotropin [Units/volume] in Urine

467

1.42

2.01

1.4

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

151

1208

1.26

2.00

2.0

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

319

1.51

2.00

1.8

2.1

8.01

8.70

umol/l

0.11

238

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.00

1.5

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

208

1724

1.22

1.99

4.5

3.6

25.69

25.11

mmol/l

1.67

201

1666

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.98

1.94

1.3

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

226

1.60

1.93

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

195

1.65

1.92

1.0

1.1

0.94

1.15

u/l

2.15

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

121

1.82

1.88

1.0

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

214

1792

1.20

1.86

7.3

5.3

1.60

1.63

0.23

208

1699

(21494755) Public health laboratory ask at order entry panel

429

4820

0.88

1.80

1.4

—

(40768806) Pleura Pathology biopsy report

475

0.63

1.78

1.9

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

219

1847

1.19

1.78

1.9

1.8

1.56

1.53

g/l

0.21

186

1609

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.34

1.77

1.6

—

(3017354) Segmented neutrophils/Leukocytes in Blood

437

1.40

1.77

2.6

3.7

55.11

56.82

0.23

381

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

200

1.60

1.76

2.2

142.22

156.72

0.48

191

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

288

1.50

1.76

1.0

792.19

697.83

ng/l

0.65

212

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

288

1.50

1.76

1.0

308.06

332.31

ng/l

0.27

216

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

370

3257

1.15

1.76

3.5

4.0

1.23

mmol/l

0.22

318

2821

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

801

1.29

1.75

1.7

1.5

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

3.34

1.74

1.2

1.4

1.47

1.34

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

209

1.58

1.73

1.2

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

162

1331

1.22

1.73

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

257

1.52

1.73

1.1

1.0

0.42

1.75

u/ml

0.60

(3003694) ABO and Rh group [Type] in Blood

1317

12414

1.08

1.72

1.5

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

724

1.30

1.72

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

724

1.30

1.72

1.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

440

1.39

1.71

1.1

—

2.44

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

258

1.52

1.70

1.1

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

291

1.48

1.69

1.0

38.35

43.54

ng/l

0.39

215

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.16

1.66

1.0

0.03

0.22

u/ml

—

(3005033) Fetal Nuchal fold Thickness US

490

0.65

1.65

1.6

1.5

1.25

1.29

0.18

344

(3043238) Trisomy 21 risk [Likelihood] in Fetus

514

0.66

1.65

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

426

1.39

1.65

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

113

898

1.26

1.64

2.9

3.3

57.37

58.19

0.27

113

898

(3014599) Egg white IgE Ab [Units/volume] in Serum

253

1.51

1.62

1.0

0.80

0.85

u/ml

0.04

(3047352) Trisomy 18 risk [Likelihood] in Fetus

499

0.66

1.61

1.6

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

629

0.70

1.61

1.6

1.5

57.84

59.43

ug/l

0.09

514

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.84

1.61

1.2

—

(4281824) Cell count and differential, peritoneal fluid

534

0.67

1.60

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

2.50

1.59

1.1

1.2

50.00

68.84

ug/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.33

1.58

1.3

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

605

1.31

1.54

1.1

4.81

3.84

u/ml

0.17

254

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

536

1.33

1.53

1.2

7.48

7.39

mmol/l

0.09

474

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

124

1010

1.23

1.48

5.9

6.2

435.22

2103.28

iu/ml

0.55

145

(3023410) Appearance of Cerebral spinal fluid

402

1.37

1.47

1.3

1.6

—

(3047181) Lactate [Moles/volume] in Blood

142

1175

1.21

1.46

8.5

6.5

1.46

1.35

mmol/l

0.45

133

1038

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

581

0.70

1.46

1.6

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

699

1.28

1.45

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

709

1.27

1.44

1.1

8.31

972.89

iu/ml

0.56

140

(3021387) Prolactin [Units/volume] in Serum or Plasma

151

1260

1.20

1.43

1.6

1.8

279.49

311.28

mu/l

0.97

138

1152

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.73

1.43

1.0

9.27

8.55

mmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

338

3006

1.13

1.43

1.9

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

192

1638

1.18

1.43

7.8

5.6

0.87

0.88

0.10

186

1551

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.79

1.42

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

589

0.71

1.42

1.5

1.38

1.18

ratio

0.53

353

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

589

0.71

1.42

1.5

0.93

0.96

ratio

0.30

352

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

589

0.71

1.42

1.5

1.15

1.14

ratio

0.01

352

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

200

0.50

1.41

1.6

2.6

150.30

145.84

nmol/l

—

177

(3036071) Salmonella sp Ab [Titer] in Serum

118

1.70

1.41

1.2

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

149

1.61

1.40

2.3

—

(4034850) Laboratory test

141

1172

1.21

1.40

10.0

8.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.38

1.2

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.00

1.38

1.1

6.97

10.27

u/ml

0.39

(3042631) Mycobacterium sp identified in Specimen

546

1.30

1.37

2.5

2.7

—

(3017704) Immunofixation for Urine

190

1.53

1.37

2.0

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

298

1.41

1.35

1.6

1.8

1.64

1.90

u/field

0.10

157

(3011288) Drugs identified in Urine by Screen method Nominal

112

914

1.23

1.34

1.4

2.7

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.13

1.33

1.4

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.04

1.32

1.4

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.74

1.30

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

648

1.27

1.30

1.1

3.07

2.60

u/ml

0.11

310

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.50

1.30

2.7

2.1

48.67

42.00

umol/l

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

217

1.48

1.30

1.4

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

217

1.48

1.30

1.4

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

217

1.48

1.30

1.4

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

217

1.48

1.30

1.4

2.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.09

1.30

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

129

1.63

1.29

1.0

1.4

69.86

415.08

nmol/24h

0.91

129

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

543

1.29

1.6

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.78

1.28

1.2

1.1

39.72

36.66

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.78

1.28

1.2

1.1

7.96

8.61

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.78

1.28

1.2

1.1

22.08

22.43

—

(3044927) Protein electrophoresis panel - Urine

344

1.37

1.27

1.3

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

553

1.29

1.27

1.1

1.0

0.87

0.24

u/ml

0.49

159

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

651

1.26

1.1

1.47

1.51

g/l

0.34

599

(40768446) Kidney Pathology biopsy report

194

1.50

1.26

1.9

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

107

876

1.23

1.26

2.1

1.8

0.88

0.84

nmol/l

0.30

740

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

170

1.53

1.25

1.2

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

170

1.53

1.25

1.2

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

458

1.31

1.25

1.3

1.63

1.46

nmol/l

0.51

408

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.63

1.21

1.2

171.80

155.07

ug/g

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

356

1.35

1.21

1.5

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.80

1.21

1.5

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

117

975

1.20

1.17

2.0

2.1

132.24

130.75

g/l

0.27

742

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.93

1.17

1.3

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

704

1.24

1.16

2.8

3.6

1.98

1.68

0.26

639

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.75

1.12

1.6

1.5

1.16

1.17

mmol/l

0.49

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

1.12

2.1

2.6

—

(3024869) Neuronal Ab [Presence] in Serum

1.90

1.12

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

294

0.64

1.11

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

476

1.29

1.11

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

328

1.34

1.10

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1061

0.82

1.10

1.6

1203.78

1038.02

mu/l

0.62

875

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.38

1.09

1.0

2.08

2.15

iu/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

346

1.33

1.09

1.9

1.7

3.14

4.08

mg/l

1.90

334

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

292

0.65

1.08

1.4

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.19

1.08

1.7

2.8

0.29

0.59

u/field

—

(3033099) Centromere Ab [Titer] in Serum

1.69

1.07

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.87

1.07

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

785

1.21

1.06

2.5

2.9

546.07

1512.27

u/ml

0.84

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.12

1.05

1.0

1.3

1.67

1.70

umol/24h

—

(3047189) Immunofixation for 24 hour Urine

178

1.46

1.05

1.8

2.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

237

1.40

1.04

1.3

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

237

1.40

1.04

1.0

1.25

2.02

u/ml

0.15

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

280

1.36

1.03

1.2

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.27

1.03

1.4

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

670

1.23

1.03

1.5

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

288

0.66

1.03

6.8

3.02

40.12

ug/l

2.04

189

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.06

1.02

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.06

1.02

1.1

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

482

1.27

1.02

1.2

52.32

63.24

u/l

1.18

418

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

230

1.39

1.01

1.3

1.5

—

783425.00

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.81

0.98

1.4

1.2

298.39

105.48

ng/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.18

0.98

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

119

1014

1.18

0.98

2.8

2.2

4438.36

4379.98

u/l

0.01

413

(4211845) Urine protein measurement

181

1.44

0.98

3.6

2.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

112

950

1.18

0.97

2.1

2.5

168.49

94.17

ug/min

0.51

600

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

327

1.32

0.97

2.1

1.9

16.33

15.34

0.24

320

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.95

0.97

1.0

1.1

—

(3019174) dRVVT (LA screen)

1.95

0.97

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

149

1295

1.16

0.96

1.3

1.2

63.08

124.82

titre

1.51

114

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

502

0.76

0.95

1.5

1.6

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

182

1.43

0.95

1.2

1.1

13.38

10.39

mm/h

0.38

182

(3020717) Zinc [Moles/volume] in Serum or Plasma

233

1.38

0.95

1.2

1.4

17.07

23.43

umol/l

0.73

213

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.69

0.95

10.2

10.7

4.83

5.86

mmol/l

0.91

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

105

889

1.19

0.94

1.5

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

373

1.29

0.93

1.2

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.22

0.93

2.0

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

109

928

1.18

0.92

1.7

1.5

—

(3001729) Color of Synovial fluid

2.14

0.91

1.0

1.6

—

(40768793) Breast Pathology biopsy report

1102

0.84

0.91

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

360

0.72

0.90

1.1

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

236

1.36

0.89

1.8

1.5

1.00

1.38

nmol/l

0.95

166

(3028433) Virus identified in Specimen by Culture

135

1.48

0.89

1.1

1.2

—

(3012898) Urea [Moles/volume] in Urine

1.82

0.85

1.6

1.3

235.63

147.24

mmol/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

164

1851

0.88

0.85

1.1

0.54

0.62

ratio

1.78

276

(3013637) Mi-2 Ab [Presence] in Serum

120

1.50

0.85

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

120

1.50

0.85

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

120

1.50

0.85

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

120

1.50

0.85

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

317

1.30

0.85

2.2

2.1

—

(3006462) Nitrate [Presence] in Urine

170

1.41

0.85

3.8

2.9

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

696

1.20

0.85

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

406

1.26

0.84

3.0

4.1

—

(1175426) CD3 cells/Lymphocytes in Blood

335

1.29

0.84

2.3

1.9

73.05

72.74

0.05

326

(3044009) aPTT.lupus sensitive (LA screen)

1.94

0.84

1.5

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.78

0.84

1.3

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

266

1.32

0.82

1.2

1.1

18.34

24.89

u/l

0.55

240

(3008037) Lactate [Moles/volume] in Venous blood

112

967

1.16

0.82

2.9

2.8

1.54

1.58

mmol/l

0.20

103

939

(40768800) Prostate Pathology biopsy report

110

950

1.16

0.81

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

154

1363

1.13

0.80

3.5

3.2

0.35

0.33

iu/ml

0.12

741

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

646

1.20

0.79

1.7

1.4

0.38

0.34

nmol/l

0.22

458

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

9.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

268

1.31

0.79

1.2

1.1

74.94

85.95

u/l

0.52

242

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

156

1.41

0.78

1.0

1.1

12.32

5.93

u/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.78

0.0

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

182

1.38

0.77

1.1

128.90

186.97

iu/ml

1.17

182

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

269

1.30

0.77

2.0

1.6

42.00

23.44

u/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

217

1.34

0.76

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

226

1.33

0.76

1.5

2.2

7.68

8.43

mmol/l

0.80

226

(3012441) Differential panel - Pleural fluid

449

0.78

0.75

1.7

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.57

0.74

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.57

0.74

1.1

371.17

301.57

pmol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.67

0.74

1.7

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

414

1.23

0.74

1.3

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

159

1420

1.12

0.74

2.9

3.3

1.48

1.51

mg/l

0.18

143

1314

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

228

1.32

0.72

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.61

0.72

1.3

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.67

0.72

1.3

1.8

—

(21494814) CD8 cells/Lymphocytes in Specimen

194

1.34

0.71

2.2

1.8

29.50

30.77

0.14

194

(1616796) Gas panel - Central venous blood

104

906

1.15

0.71

3.0

3.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

776

1.16

0.70

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.55

0.69

1.3

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

248

1.29

0.68

2.9

3.0

38.90

40.44

0.17

128

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

347

1.24

0.67

1.3

1.2

—

197.27

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

347

1.24

0.67

1.3

1.2

440.00

178.91

titre

—

(3001556) Androgen free Index in Serum or Plasma

1.79

0.66

1.0

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

111

1.44

0.65

1.3

1.2

9.15

11.03

pmol/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

216

1.30

0.63

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.50

0.63

6.8

7.2

10.73

10.51

0.15

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

441

4669

0.94

0.62

3.6

4.8

4.43

30.66

ug/l

5.22

349

3798

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

843

1.14

0.61

1.7

1.5

150.66

145.20

au/ml

0.18

253

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

131

1174

1.12

0.61

1.9

2.1

68.68

8.89

iu/l

0.44

502

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.57

0.60

1.3

1.2

72.25

68.02

ug/l

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

165

1.33

0.60

7.8

1.5

243.75

100.45

umol/l

0.76

(3024666) Lithium [Moles/volume] in Serum or Plasma

244

0.74

0.60

15.0

12.1

0.61

0.63

mmol/l

0.14

217

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

236

1.27

0.59

1.2

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.59

0.0

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

1.53

0.59

1.7

2.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

157

1.34

0.59

1.1

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.58

0.0

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

373

1.21

0.57

1.5

1.3

391.89

166.00

pmol/l

0.57

373

(3045788) Cell count panel - Pleural fluid

409

0.81

0.57

1.8

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.48

0.57

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

132

1.36

0.57

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

764

1.14

0.57

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

721

0.86

0.56

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.46

0.56

1.1

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

550

1.17

0.56

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

124

1.37

0.55

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

122

1097

1.11

0.55

1.2

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

275

1.24

0.55

1.2

100.92

88.24

u/l

0.24

229

(1761482) Bacteria [#/volume] in Urine by Culture

101

899

1.13

0.54

4.0

3.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.58

0.54

1.0

1.1

5.17

15.97

u/l

—

(3020491) Glucose [Moles/volume] in Blood

285

1.23

0.54

2.0

1.9

7.11

6.62

mmol/l

0.65

191

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

340

1.21

0.53

1.6

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

160

1.31

0.53

2.6

3.0

0.63

0.61

mmol/l

0.86

160

(3052592) Norovirus Ag [Presence] in Stool

1.45

0.53

1.0

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

268

1.23

0.52

1.2

16.91

22.23

u/l

0.42

217

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

241

1.25

0.52

1.2

1.4

—

(4198724) Urine methamphetamine measurement

146

0.68

0.52

1.7

1.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.45

0.51

1.5

2.1

2.32

2.52

ug/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.46

0.50

1.3

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

153

1.31

0.50

1.5

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

153

1.31

0.50

1.5

2.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

127

1.34

0.49

1.0

1.1

62.78

70.23

u/ml

0.15

121

(40768441) Liver Pathology biopsy report

362

1.19

0.49

1.2

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

142

1298

1.10

0.49

1.3

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

154

1.30

0.48

1.5

2.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.52

0.48

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

663

1.13

0.47

2.8

3.1

0.82

0.81

nmol/l

0.05

519

(1617658) Protocol used for examination of sentinel lymph nodes

365

0.82

0.47

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

146

1.30

0.47

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

155

1.29

0.46

1.9

1265.60

25253.00

u/ml

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.43

0.46

1.0

1.6

145.43

116.89

ug/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.43

0.46

2.1

1.6

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

119

0.67

0.45

1.4

1.25

2.45

—

(37021550) Renin [Units/volume] in Plasma --upright

1.43

0.45

1.1

1.3

41.60

60.88

mu/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

112

1.34

0.44

6.8

7.2

6.12

5.28

kpa

0.48

112

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.37

0.44

1.1

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.37

0.44

1.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

130

0.69

0.43

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.61

0.43

1.0

1.1

—

(3000012) Reticulocyte production index

574

1.13

0.43

1.7

2.4

0.94

0.90

0.29

385

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

1.31

0.42

7.8

3.2

11.68

10.17

kpa

0.61

122

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

1.31

0.42

7.8

3.2

5.55

4.85

kpa

0.51

122

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.56

0.42

1.0

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.41

0.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

171

0.76

0.39

3.1

1.9

—

(3016879) Cocaine [Presence] in Urine

142

1316

1.08

0.39

1.4

1.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.41

0.39

2.7

1.4

0.44

0.49

e9/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

187

1.23

0.38

1.7

1.6

8.21

6.44

nmol/l

0.09

152

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.39

0.38

2.6

2.7

—

(3009871) Measles virus Ab [Titer] in Serum

188

1.22

0.37

1.6

3488.00

2650.00

titre

—

(3008295) Osmolality of Serum or Plasma

440

0.86

0.37

1.3

1.4

286.00

281.31

mosm/kgh2o

0.82

355

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.39

0.36

1.3

1.6

—

192.83

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

384

1.15

0.36

3.2

4.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

356

1.15

0.36

1.8

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

438

0.87

0.35

1.7

1.4

18372.74

50355.85

e6/l

1.25

234

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

117

1.28

0.35

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

501

0.88

0.35

1.6

1.5

7819.15

1902.94

e6/l

0.72

341

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

146

1363

1.07

0.35

2.7

2.6

3.72

3.60

g/l

0.49

137

1307

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.37

0.34

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

156

0.77

0.34

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.36

0.34

2.0

2.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.36

0.34

1.0

2.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.36

0.34

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

178

0.79

0.34

1.8

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

386

1.14

0.34

3.9

3.4

15.60

13.44

index

0.40

252

(3004775) Volume in Urine collected for unspecified duration

330

1.15

0.34

2.2

2.4

667.67

650.26

0.09

228

(3001019) Free T4 and TSH panel - Serum or Plasma

253

2408

1.05

0.33

1.8

1.7

—

(3006245) CD3-CD19+ cells/cells in Blood

145

1.24

0.33

2.3

2.1

7.06

9.73

0.76

136

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

118

1.27

0.33

1.1

1.3

89.43

87.12

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

387

1.14

0.33

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

624

0.90

0.32

5.0

5.9

364.16

375.84

umol/l

0.21

541

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.32

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

340

3266

1.04

0.32

4.1

3.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

532

1.11

0.31

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.33

0.30

1.2

1.5

—

(40758292) HTLV I+II Ab panel - Serum

1.29

0.30

1.2

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

572

1.10

0.29

1.2

1.1

—

0.56

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

215

2257

0.95

0.29

3.2

4.1

57.38

63.20

u/ml

0.07

204

2185

(40768795) Lymph node Pathology biopsy report

525

0.89

0.29

1.4

1.3

—

(3042733) HLA Ab [Presence] in Serum

176

1.19

0.28

6.0

4.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

718

1.09

0.28

1.3

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

355

1.13

0.28

1.1

1.3

8.19

9.26

mmol/l

1.12

332

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.28

0.28

2.0

2.8

1580.00

69.29

ug/l

0.45

(3012501) Base excess in Blood by calculation

825

1.08

0.28

3.6

4.1

2.58

2.57

mmol/l

0.01

567

(3040151) Glucose [Moles/volume] in Capillary blood

432

1.11

0.27

1.6

5.4

6.44

7.38

mmol/l

2.61

379

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

122

1.23

0.27

1.2

90.00

88.33

—

(3000034) Microalbumin [Mass/volume] in Urine

367

1.12

0.26

2.3

3.0

16.66

48.00

mg/l

1.18

275

(3045142) Bone marrow Pathology biopsy report

529

0.91

0.25

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

403

0.89

0.24

4.2

5.7

23.65

50.97

u/ml

1.37

126

(3028300) Cannabinoids [Presence] in Urine

151

1436

1.05

0.24

1.4

1.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

152

1.18

0.23

1.1

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

115

1087

1.06

0.22

1.5

1.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.77

0.22

1.6

2.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.25

0.22

1.2

5.68

6.16

mmol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

157

0.83

0.22

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.27

0.22

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.27

0.22

1.0

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.27

0.22

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.27

0.22

1.0

1.3

—

(3024932) HLA-DR beta [Type]

163

1.17

0.21

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

6.9

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3027008) Opiates [Presence] in Urine

150

1433

1.05

0.21

1.4

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

377

0.90

0.21

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

230

0.87

0.21

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

570

5580

1.02

0.20

2.1

3.52

3.50

ratio

0.20

441

4354

(3020191) Ethanol [Moles/volume] in Serum or Plasma

335

0.89

0.20

1.6

1.4

1.09

1.21

promille

0.16

260

(3013727) Leukocytes other/Leukocytes in Blood

134

0.82

0.20

2.7

3.6

48.55

53.62

0.37

129

(3001964) Herpes simplex virus Ag [Presence] in Specimen

123

0.81

0.20

1.0

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

202

1.14

0.20

1.3

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

149

1426

1.05

0.20

1.4

1.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

127

1.18

0.19

2.2

3.4

1.79

1.97

ratio

0.17

118

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

146

1.16

0.19

2.4

2.1

29.53

28.71

0.09

138

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

118

1.19

0.19

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

222

1.13

0.19

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

184

1.14

0.19

2.7

2.4

57.44

53.38

umol/l

0.20

161

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

422

4124

1.03

0.18

1.7

3.48

3.51

mmol/l

0.19

297

2877

(3010375) cycloSPORINE [Mass/volume] in Blood

238

0.88

0.18

35.7

29.2

95.88

113.46

ug/l

1.14

193

(3038515) Glucose [Moles/volume] in Venous blood

815

1.06

0.17

3.1

2.8

7.55

mmol/l

0.00

791

(3028707) Methadone [Presence] in Urine by Screen method

552

1.07

0.17

1.6

2.6

—

(3017569) Oxygen content in Arterial blood

234

1.11

0.16

1.7

2.5

16.30

16.24

0.04

234

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.18

0.16

2.1

1.7

99.82

37.63

pmol/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.20

0.16

1.2

1.1

—

(3024471) HLA-A [Type]

168

1.13

0.15

1.1

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.21

0.15

1.0

1.2

—

22.60

—

(3023183) Ammonium ion [Moles/volume] in Plasma

101

966

1.05

0.15

2.8

3.0

36.86

36.07

umol/l

0.08

894

(3004451) EKG impression Narrative

224

0.89

0.15

1.0

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

102

1.18

0.15

2.3

2.1

0.13

0.41

e9/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

491

0.94

0.14

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

122

1.15

0.13

1.2

1.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.82

0.13

1.6

3.1

126.75

3384.89

u/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

222

0.90

0.13

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

159

0.88

0.13

1.6

7.93

8.36

mmol/l

0.35

152

(3000919) Neutrophils/Leukocytes in Pleural fluid

107

0.84

0.13

1.4

27.33

15.45

—

(3043410) Blood group antigens tested for on Red Blood Cells

104

1.15

0.12

1.6

1.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1007

0.96

0.12

3.4

4.0

372.93

780.05

u/ml

0.63

928

(3025130) Human papilloma virus identified in Specimen

610

1.05

0.12

1.6

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

406

1.06

0.11

1.3

1.4

6.39

6.06

mmol/l

0.38

384

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

136

0.88

0.11

1.4

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

198

0.91

0.10

2.7

2.1

627.10

815.75

e6/l

—

135

(3027944) Amphetamines [Presence] in Urine

145

1414

1.03

0.09

1.4

1.9

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.15

0.09

2.1

2.2

12.45

17.86

umol/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

330

1.06

0.09

1.7

1.6

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.04

0.09

6.2

10.5

0.30

0.18

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

431

0.95

0.09

1.5

1.7

—

(3003181) Sodium [Moles/volume] in Urine

705

0.96

0.08

1.2

1.4

60.00

60.35

mmol/l

0.03

548

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

253

1.07

0.08

2.7

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.03

0.08

2.3

2.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.81

0.08

1.0

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

866

0.97

0.08

1.4

1.3

229.54

282.42

u/ml

1.25

549

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

128

1.09

0.06

1.6

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

376

0.96

0.06

1.4

1.5

53.31

60.24

ug/l

0.66

376

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

197

1.07

0.06

1.3

1.1

1922.71

1502.91

miu/ml

0.66

197

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

165

1676

0.98

0.06

3.3

4.1

50.40

1256.59

u/ml

2.15

142

1469

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

188

1.06

0.05

3.9

4.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.11

0.05

1.1

1.0

12.37

34.08

iu/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.11

0.05

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

198

1.06

0.05

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

198

1.06

0.05

1.4

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

901

1.02

0.05

3.4

3.1

23.00

28.05

mg/l

0.97

615

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

249

1.04

0.04

1.9

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

259

1.04

0.04

1.9

1.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

171

1.05

0.03

2.6

1.9

2712.86

18826.89

e6/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

192

1.04

0.02

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

152

1532

0.99

0.02

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

238

0.97

0.02

51.5

39.7

7.18

7.27

ug/l

0.13

214

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

333

1.02

0.01

1.3

1.6

2.62

3.96

ug/l

0.78

264

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

104

1.06

0.01

1.5

1.2

—

(21494434) Karyotype in Bone marrow

384

1.02

0.00

1.1

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

105

1.05

0.00

2.4

2.7

—

126.44

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

282

0.99

0.00

1.9

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

114

0.96

0.00

1.2

1.3

—

(4133840) Spirometry

116

1.03

0.00

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

167

1.02

0.00

1.0

—

(3035880) pH of Pleural fluid

217

1.01

0.00

1.2

1.3

7.40

7.41

0.04

147

(3014148) Varicella zoster virus Ab [Titer] in Serum

556

1.01

0.00

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

934

1.00

0.00

1.4

1.5

—

(44806420) Estimation of glomerular filtration rate

553

0.99

0.00

2.5

2.4

—

(3051101) Glucose [Moles/volume] in Cord blood

0.93

0.00

6.4

8.0

6.80

8.49

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.91

0.00

1.6

1.3

—

(44806071) Cardiolipin IgM antibody measurement

0.91

0.00

1.4

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

2.6

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.00

-0.00

1.1

1.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.2

—

3.00

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

190

1.00

-0.00

1.8

3.6

1.29

1.48

0.27

190

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.96

-0.00

1.3

1.7

—

5606.25

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.3

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

53.96

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.67

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.58

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

280

1.00

-0.00

1.4

1.5

22.45

7.16

u/l

0.78

224

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

44.17

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

1706.75

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

11.7

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

115.42

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

4.40

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ACHILLESTEND and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_ACHILLESTEND	0.902 [0.8, 1.02]	0.095
Birth year	0.994 [0.99, 1.0]	0.166

During the follow-up period (1.1.1998 — 31.12.2019), 623 out of 9742 females with M13_ACHILLESTEND died.

Males

Parameter	HR [95% CI]	p-value
M13_ACHILLESTEND	0.776 [0.69, 0.87]	< 0.001
Birth year	0.984 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 892 out of 10400 males with M13_ACHILLESTEND died.

Mortality risk

Mortality risk for people of age

years, who have M13_ACHILLESTEND.

N-year risk	Females	Males
1	0.06%	0.109%
5	0.485%	0.708%
10	1.193%	1.932%
15	2.506%	3.762%
20	4.409%	6.826%

Relationships between endpoints

↥

Index endpoint: M13_ACHILLESTEND – Achilles tendinitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Achilles tendinitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints